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ABSTRACT 
Twenty-three strains of Histoplasma capsulatum were 
studied. The data indicated that each strain had individual 
characteristics with regard to; macroscopic appearance of 
colonies, measurement of spore sizes 9 relative number of 
spores j virulence as determined by intravenous LD50 in mice, 
immunization capacity of vaccines, and chemical composition 
of the vaccines prepared from four strains. Strains G10} 
G17M9 2645, and 3330 were used to study the immunogenicity 
of the fungus. A cell free extract prepared from the 
mycel ial phase of strain G10 and a cell free extract prepared 
from the yeast phase of strain G17M produced similar protection 
in immunized mice. G10 and G17M vaccines also had similar 
chemical composition with high carbohydrate content and low 
protein content. Strains 3154 and G17M were found to be 
the most virulent by the method employed. The sporulation 
number~ as determined by a rank rating system, showed that 
each strain produced various numbers of both types of spores. 
The results indicated that Sabouraudis medium with phosphate 
ion produced abundant and numerous spores. The macroscopic 
description of each strain on various media indicated that 
each strain varies in morphological characteristics depending 
on the nutrition available. 
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IMMUNITY TO HISTOPLASMOSIS INDUCED IN MICE BY 
COMPONENTS OF HISTOPLASMA CAPSULATUM 
INTRODUCTION 
The extent and mechanisms of resistance to histoplasmosis 
represent an area of significant basic and appl jed effort 
in mycology. The problems associated with the antigenic 
analysis of Histoplasma capsulatum are as complex as the 
fungi themselves. In its natural habitat of soils or on 
agar incubated at room temperature 1 the fungus forms an 
intricate network of interlaced hyphae~ from which a 
special ized complex of spores are produced. The large, 
globose macroconidium, characteristic of H. capsulatum, 
has a thick wall, internal structure~ and many short j 
finger-l ike appendages emanating from all sides. In addition 
there exists a second type of spore called the microconidium. 
The smooth-wal led microconidium is spherical or pyriform in 
shape. It is possible that the constitution of the macro-
conidium is not identical with that of the microconidium. 
Two other elements exist which may also be different in 
composition: the yeast phase of the organism and the hyphal 
elements. 
The objectives of the work presented in this thesis 
have been: a) preparation of vaccines from various elements 
2 
of ~o capsulatum in order todetermine immunogenic capacity; 
b) characterization of the virulence of selected yeast 
phase strains of the organism by intravenous LDSO; c) 
differential spore production on various media; and d) 
description of the macroscopic appearance of strains of the 
fungus on various media. 
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REVIEW OF LITERATURE 
Increased awareness in recent decades of the prevalence 
of airborne fungi and the high frequency of these organisms 
as etiological agents of pulmonary disease has stimulated 
wide-spread interest in their pathogenicity and immuno-
genicity. The defense mechanisms are 1 ittle understood in 
the mycoses. Antibodies arising during the course of disease 
have high diagnostic and prognostic values but the protective 
effect of such antibodies has not been demonstrated Cellular 
responses to infection with these organisms produce granu-
lomas and delayed hypersensitivity. Such reactions are 
sal ient features 9 the former is associated with heightened 
immunity but the role of the latter is undetermined, 
I. HISTORY OF HISTOPLASMOSIS 
The causal agent of histoplasmosis was first observed 
by Darl ing (1906, 1908~ 1909). He bel ieved the organism to 
be a protozoan and gave it the generic name, Histoplasma. 
The species name 9 capsu1atum, was used to describe a 
capsular-appearing halo surrounding the organism in stained 
tissue sections. Da Rocha-Lima (1912) was the first to 
suspect that the organism was actually a fungus and not a 
protozoan. ~. capsulatum was obtained in culture by Hansmann 
and Schenken in 1934 and a complete description of the 
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organism was publ ished by De Monbreun in 1934. De Monbreun 
clearly demonstrated the diphasic nature of the fungus and 
accurately described the cultural characteristics, morphology 
and 1 ife cycle of the organism. Ciferri and Radael 1 i (1934) 
stated the systematic position of ~. capsulatum as fol lows: 
genus Histoplasma 9 order Blastosporales, superfamily 
Atelosaccharomycetaceae, and family Histoplasmaceae Since 
no sexual stage could be demonstrated for ~Q capsulatum 9 
Conant (1941) placed the organism in the Fungi Imperfecti, 
as a member of the form-family Monil iaceae. However sexual 
reproduction has been demonstrated by Ajello and Cheng (1967), 
The development of an ascigenous state was stimulated on soil 
overlaid with feathers. The organism is homothall IC and is 
given the perfect state name of Gymnoascus demonbreunni i. 
A diagrammatic representation of the 1 i cycle of ~. 
capsulatum and Go demonbreunni i is shown in Figure 10 The 
three cycles represent the mycel ial and yeast phase of the 
asexual ~. capsulatum and the sexual stage of the fungus 
G. demonbreunni i. The various structures, forms, and spores 
are depicted. Recently the val idity of the species G. 
demonbreunni i as the perfect state of H. capsulatum has been 
questioned (Kwon-Chung, 1968). 
Knowledge of the growth of ~. capsulatum in nature 
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Figure 1. A diagrammatic representation of the 1 ife cycle 
of Histoplasma capsulatum and Gymnascus demonbreunni i 
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(1949). They isolated the organism from the soil about a 
rodent burrow under a chicken coop. Grayston, Loosl i, and 
Alexander (1951) reported the first isolation of the organism 
in connection with an epidemic of histoplasmosis which 
occurred in a silo in Northern Indiana. This fungus grows 
in the soil and is inhaled after the soil is stirred by 
some activity which creates an aerosol, In general, these 
organisms are smal 1 ~ 5 u or less in size (Cozad and Furcolow, 
1953). Thus j in an aerosol these organisms can readily 
penetrate to the alveolar bed and be retained there (Brown, 
Cook, Ney, and Hatch, 1950), Dodd and Tompkins in 1934 
described the first antemortem description of histoplasmosis. 
Following the publ ication of this work, fatal cases were 
recognized with increasing frequency, However? it was still 
regarded as a rare and fatal human disease. 
In the 1940ls a series of events conspired to change 
this situation. Christie and Peterson (1945) reported on 
pulmonary calcification with negative tubercul in tests in 
the Mississippi Valley area. Palmer (1945) incorporating 
histoplasmin skin testing in a broad survey on tubercul in 
sensitivity demonstrated a strong epidemiologic correlation 
between the incidence of pulmonary calcifications and positive 
histoplasmin skin test in individuals with negative tuber-
cul in skin tests. These discoveries permitted a new 
evaluation and understanding of the epidemiology of the 
disease produced by ~. capsulatum. 
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Histoplasmosis has been found to be an intracellular 
mycosis of the reticuloendothel ial system. Usually respira-
tory in origin, histoplasmosis may be asymptomatic or benign, 
acute or chronic, and widely disseminated or fatal. 
~. capsulatum parasitism of reticuloendothel ial cells 
probably results in early and wide dissemination even in 
mild or inapparent disease (Emmons~ Binford and Utz~ 1963), 
Histoplasmosis is a disease of worldwide distribution. 
The hypothesis has been suggested that all of the river 
valleys in the temperate and tropical zones of the world, 
between 45 0 north and 45 0 south latitude are endemic areas 
(Furcolow, 1960). It has been estimated that in the United 
States alone 30 mill ion people have been infected with this 
fungus? and half a million a year acquire the infection 
(Furcolow j 1965). 
I I. MORPHOLOGICAL AND 
A. Mycel ial Phase 
When mycel ial fragments are streaked over Sabouraud's 
dextrose agar, small white, cottony colonies develop which 
increase in size. At the time maximum growth is reached~ 
the central portion and upper drier parts of the culture 
assume a yellow to buff color which slowly turns to tan or 
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dark brown. Gradually the entire culture will become 
brown in color and will take on a drier more fragile or 
powdery appearance. Usually sporulation is associated with 
the tan coloration and aging of the culture (Pine, 1960)0 
In general, the mycel ium varies from 1 - 5 u in diameter. 
The hyphae are usually refractile, branched, and multicellular 
(septate). Each mycel ial cell component has one or more 
nuclei (Negroni j 1940). When the mycel ium becomes older, 
its protoplasm is displaced toward the walls and vacuoles 
and oil globules are seen in the central portions of the 
cells. At this time 9 the walls thicken and a few cells may 
develop into pecul iar appearing swell ings of assorted shapes 
and sizes which in some cases reach a diameter as great as 
15 u. Racquet hyphae and occasionally coiled hyphae and 
nodular bodies may be formed while intercalary chlamydospores, 
single and in chains, and ranging from 5 - 8 ~ in diameter 
may be found in most cultures. As the hyphae spread in 
radiating fashion from the center of the colony, parallel 
hyphae lying at the periphery may be observed to undergo 
anastomoses. These hyphal fusions do not result in the 
apparent formation of any special ized structures, 
ti. capsulatum produces two types of ale uri os pores, 
macroconidi p and microconidia (Howell ~ 1939). The 
macroconidia are typically large tuberculate 1 spherical to 
pyriform spores described as ranging from 10 - 25 u 
(Pine, 1960), or 8 - 14 u (Emmons~ Binford j Utz, 1963). 
These macroconidia are formed in the aerial portions of 
the mycel ium generally at the end of short pedicels but 
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may be sessile or formed at the end of long hyphae (Pine? 1960)0 
As described by Howell (1939) the large aerial spores 
begin their development as bulbous enlargements on the ends 
of lateral branches and are called spore initials o These 
branches may be simple with a single spore on the end of 
each branch~ or one to several spores may be produced acro-
peta1ous1y and directly on a short branch. As these spore 
initials or prespores increase in size, the spores become 
spherical to pyriform in shape and their walls gradually 
increase in thickness. 
The character of the spore wall varies greatly with the 
strain examined, the medium used, or the part of the mycel ium 
in which it is produced (Howell, 1939). In addition to 
tuberculate and smooth macroconidia, there are forms having 
only several large bulbous or convoluted swell ings or numerous 
spindly or warty projections (Negroni, 1940). Preponder-
antly smooth-wal led macroconidia have been noted deep in the 
mycel ial mat next to or embedded in the agar (Howell, 1939). 
Certain spores formed in these regions exhibit a halo of 
substance surrounding the body of the macroconidium and have 
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been cal led nymbospores (Nielsen and Evans~ 1954)0 The 
spines or finger-1 ike projections may be 1 - 8 u in length 
(Conant, 1941) but average about 5 u o It is the tuberculate 
spore which serves to identify the fungus. 
The optimum pH for growth of the myce1 ia1 phase on a 
synthetic medium is approximately pH 6 0 5 (Howell, 1941). 
At pH 505 to 6.5 considerable aerial myce1 ium and macroconidia 
were formed on this medium whereas at pH 7.7 - 8.6 there was 
1 ittle or no aerial mycel ium and sporulation was negl igiblea 
The optimum temperature for growth ranges from 25 0 to 300 C9 
and temperatures greater than 320 C are usually inhibitory 
(Howell, 1940). Based on optical density measurements~ a 
generation time of approximately 12 hours has been obtained 
at 25 0 C in shake culture (Pine, 1954)0 A high humidity is 
recognized as usually being beneficial on agar media (Menges, 
Furcolow~ Larsh and Hinton y 1952). The organism is a strict 
aerobe and growth will be greatly inhibited by merely closing 
off the culture tube with a rubber stopper or by attempting 
to grow the organism beneath the agar surface (De Monbreun 
1934)0 
Vitamin requirement studies of li. capsu1atum show variable 
results o Scheff (1945) has reported li. capsulatum required 
biotin and niacin. However, Salvin (1949) studied different 
strains of the fungus and found that no vitamin supplement 
1 1 
was necessary. The amino acid requirement of the mycel ial 
phase has been reported to be complex and variable for 
different strains (Rowley and Pine, 1955)0 Scheff (1945) 
obtained dry weights of mycel ial mass with various carbo-
hydrates; glucose, maltose and sucrose yielded the greatest 
weight increases. 
Although the consensus of opinion is that the mycel ial 
phase is readily grown at 25 0 C on a variety of media with 
relatively few nutritional requirements, the need for 
additional growth factors at 37 0 C is indicated (Howell, 
1948; Scherr, 1956; 1957). The simplest basal medium for 
the growth of the mycel ial phase is the glucose-asparagine 
synthetic medium used by Salvin (1949). However, general-
izations should be guarded because each strain has its 
own pecul iar characteristics regarding nutritional requirements, 
responses to temperature, and other environmental conditions. 
8. Sporulation 
Sporulation is dependent upon the strain of the 
organism and upon the environmental conditions of the 
culture. The addition of whole blood and temperatures 
greater than 320 C inhibit sporulation (Howell, 1940)Q 
Some strains sporulate better at pH values ranging from 
6.5 to 7.5. Such increased sporulation may be correlated 
with greater growth. Negroni (1940) has shown that 
1 2 
sporulation may be greatly affected by the carbohydrate 
or nitrogen source in the medium. For example~ in a glu-
cose containing medium, asparagine supported best growth 
at room temperature, but only macroconidia were formed. 
When KN03 was substituted for asparagine as the nitrogen 
source less growth occurred and many smooth and rough 
macroconidia were formed. Util izing (NH4)2S02 as the 
nitrogen source, this inorganic chemical resulted in 1 ittle 
growth with only smooth macroconidia and ~icroconidia being 
developed, and when no nitrogen source was added~ Negron! 
found abundant microconidia and a few smooth macroconidia 
with scant mycel ial growth. 
Artis and Baum (1963) studied 32 strains of H capsulatum 
focusing on the abil ity of these strains to form tuberculate 
spores. Nine strains did not produce tuberculate spores 
on Sabouraud's agar 9 on corn meal agar 9 on "spent" medium~ 
or media with pH values ranging from 405 to 7.0 Tuberculate 
spore production did occur in these nine strains when 
Sabouraud's medium was enriched with phosphate especially 
KH2P04° 
Smith and Furcolow (1964) suggested that the addition 
of infusions of starl ing manure to soil had the effect not 
only of producing more total particles but of producing a 
large number of microconidia and of increasing the viabil ity 
1 3 
of these spores to at least twice that observed in other 
media Q Of particular interest was the observation that 
although large numbers of particles are produced on Sabouraud~s 
medium, 84% of these particles were hypha1 elements and not 
spores 9 and the overall viabi1 ity was only 3%. 
Smith (1964) has reported that 0.6% yeast extract and 
2% agar in distilled water stimulated rapid growth and 
sporulation of H. capsu1atum similar to sporulation in 
star1 ing manure extract medium. This rapidly grown fungus 
developed many viable microconidia despite a scant growth 
of vegatative myce1 ium. 
Ho capsulatum spores are resistant to drying and will 
remain viable in dry soil during an observation period of 
4 years (Pine and Peacock, 1958). They are resistant to a 
temperature of 45 0 C for 30 minutes (Negron!, 1940). All 
spores of these strains were killed at a temperature of 500 C 
for 1 hour or at a temperature of 600 C for 5 minutes. The 
spores will survive over an observation period of 600 days 
in water at 40 C but rapidly decrease in viabil ity as the 
temperature is increased to 370 C (Cooke and Kobler, 1953~ 
Ritter~ 1954). 
C. The Yeast Phase 
The yeast phase cells of young cultures are oval bodies 
which are approximately 1.5 to 2.0u by 3.0 to 3.5u 
(Negroni, 1965) 
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Budding occurs at either pole or may be 
apolar~ with as many as three buds formed on a single mother 
cell. The cells usually appear round or oval, but elongated, 
swol len, or dumbbell shapes are also observed (Pine, 1960) 
The cells have a thin cell wall) the cytoplasm contains oil 
droplets and the nuclei of yeast cells appear peripherally 
as crescent shaped masses (De Monbreun, 1934). A halo 
about the cells appears to be a capsule, however India ink 
preparations do not reveal a true capsule (Conant, 1941), 
Ribi and Salvin (1956) were unable to find any electron-
microscopic evidence for the presence of a capsule. 
The optimum pH for yeast phase growth is considered 
to be between 6.5 and 7.5. Cross (1948) tested the effect 
of pH on the yeast-phase growth in three different media. 
Best growth was supported by brain-heart infusion broth 
at a pH range of 7.2 to 7.6. Salvin (1947) found that the 
maximum growth of the yeast-phase occurred between pH 603 
and 8.1. On basal agar medium supplemented with whole 
blood 1 the rate of growth was similar at pH 5.5, 6.5, and 
7.5 (Pine, 1954). 
In general, the growth of the yeast phase on blood 
agar or serum media occurs at temperatures between 340 and 
370 C. At lower temperatures conversion of the yeast phase 
to the mycel ial phase occurs. However} growth of the yeast 
1 5 
phase of H. capsulatum of strains studied may be maintained 
at temperatures of 25 0 C (Pine, 1957; Scherr 1 1956). Growth 
oft hey e a s t p has e iss t ric t 1 y a e rob i c (P i n e, 1 954) Din 
1 iquid shake tubes the generation time ranges from 9 to 11 
hours under optimal conditions (Pine and Peacock, 1958) 
while on blood agar media the generation time varies from 
6 to 8 h ou r s (P i n e, 1 955 ) . Row 1 e y and Hub e r (1 956 ) 
inoculated mice with non-lethal doses of the yeast phase 
and estimated the generation time to be 15 to 19 hours. 
Howard (1964) determined the intracellular generation time 
in mouse histocytes to be 10.3 ~ 1.5 hours. 
As a carbon source, Negroni (1940) found glucose j 
mannose, or mannitol supported best growth. Salvin (1949) 
in a survey on the abil ity of the yeast phase to assimilate 
various nitrogen compounds found that only cysteine, cystine 
and glutathione were assimilated. The vitamins necessary 
for growth were reported to be biotin (Salvin, 1949), 
thioctic acid (Pine, 1957) thiamine, inositol and niacin 
(McVeigh and Morton, 1965). 
I I I. DEMONSTRATION OF IMMUNITY TO HISTOPLASMOSIS 
A prerequisite for the demonstration of enhanced 
resistance is the use of a susceptible host. The subject 
of host range of H. capsulatum has been reviewed recently 
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(Salvin, 1963). The most widely used laboratory animal 
has been the mouse. The extent of immunity as measured by 
survival after challenge has been frequently employed, 
especially when high challenge doses are used. The mortal ity 
endpoint generally requires observation periods of several 
weeks to months. Marcus and Rambo (1952) reported on the 
determination of LD50 values for yeast phase cells injected 
intravenously and noted differences in virulence of two 
strains of H. capsulatum. 
In growing bacteria and viruses, the organisms obtained 
are generally quite uniform in size and morphology. in 
contrast, cultures of Coccidioides immitis and ~. capsulatum 
vary not only in size and shape but are often multiform in 
a given medium. Wit~ C. immitis for example 7 four distinct 
morphological forms may be found: 1) spherules, 2) endospores, 
3) arthrospores, and 4) myce1 ia1elements. Likewise H. 
capsulatum exists in four forms: 1) yeast phase cells, 
2) mycel ial elements, 3) macroconidia, and 4) microconidia. 
It is now known that antigenicity varies with the 
morphological phase of different fungi. Kaufman and Blumer 
(1966) in studies with a fluorescent antibody for the yeast 
phase of H. capsu1atum determined the occurrence of yeast 
phase serotypes. The yeast phase cells of H. capsulatum 
are highly immunogenic (Hill and Marcus, 1959). Mycel ial 
culture filtrates of this fungus also induce a low order 
1 7 
of resistance (Salvin, 1953). It is apparent, then, that 
there are resistance-inducing immunogens common to both 
phases. 
Marked difference in protective immunogenicity was 
observed between the saprophytic and parasitic phases of 
C. immitis. Mycel ial elements and arthrospores killed with 
formal in protected mice against low challenge doses by the 
intraperitoneal route (Converse, Castleberry, Besemer and 
Snyder, 1962; Friedman and Smith, 1956; Pappagianis, Miller, 
Smith, Berman, Kobayashi, 1961). Levine 9 Cobb, and Smith 
(1960; 1961) observed that spherules and endospores afforded 
stronger protection to mice against intranasal challenge 
doses than did either mycel ial elements or arthrospores, 
Using mycel ial elements and spherules grown simultaneously 
in the same flasks of medium, Kong and Levine (1967) observed 
that mice vaccinated with spherules were protected against 
a challenge of approximately 200 LD50 compared with 
approximately 20 LD50 in mice vaccinated with mycel ial elements. 
Employing C. immitis arthrospores, Friedman, Smith and 
Gordon (1955) studied three strains for comparative virulence 
in mice. The animals were inoculated intraperitonea11y; using 
three different parameters, the strains showed differing 
virulence with respect to each other. The authors concluded 
that virulence is relative and the ideal comparison is made 
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if the same number of viable particles of each strain has 
been inoculated into the animals. Inocula containing 100 
viable arthrospores per mill 11 iter were used The order 
of virulence from the greatest to the least was Silveria 
Perry? and Mauser strains" 
Using spherules harvested from mice infected with 
arthrospores Pappagianis, Smith? and Kobayashi (1956) 
determined the virulence of the in vivo form of Co immitis, 
The spherules were ruptured releasing their endospores, 
The endospores of both strains studied did not show a signifi-
cant difference in the virulence of endospores and arthro-
spores. 
Levine, Cobb 1 and Smith (1960) described aspects of 
protective immunity induced in mice by formal in-ki1 led and 
purified, mycel ial, arthrospore or spherule-endospore 
vaccines. Intramuscular immunization with 1.6 mg of each 
preparation resulted in the spherule-endospore vaccine 
conferring superior protection to that of the mycel ial or 
of the arthrospore preparations? to intranasal challenge 
doses of 79 to 318 arthrospores. The spherule-endospore 
preparation was administered in several doses. Better 
protection was obtained than the same amount given in a 
single dose. 
P app ian i set a 1 ., (1961) i mmun i zed mice wit h vi ab 1 e 
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C. immitis. Mice vaccinated with dead arthrospores survived 
intraperitoneal challenge doses but not the intranasal challenge, 
Mice immunized with viable arthrospores developed a high 
level of protection surviving both intraperitoneal and 
intranasal challenge doses. 
The c u 1 min a t ion 0 f the stu d yon i mm un i t y 0 f C. i mm i tis 
has been the study of the immunogenic properties of non-
disrupted and disrupted spherules by Kong, Levine~ and Smith 
(1963). Studies on the cellular fractions demonstrated 
that the soluble fraction did not afford protection against 
a challenge dose of 44 arthrospores. The particulate 
fraction which contained spherules cell walls afforded 
protection against a challenging dose of 10 2 arthrosporeso 
The recombined fraction showed that the primary immunogenic 
substance of the spherule was in the cell wall. 
The maturation cycle of the tissue phase, pecul iar to 
C. immitis illustrates an additional relationship between 
morphology and immunogenicity. Levine, Kong, and Smith 
(1965) showed that immunogenicity increased as the spherule 
matured and endosporulated. The increase in immunogenicity 
apparently reflected concomitant biosynthetic developments 
in the wall, which was shown to contain virtually all the 
immunogen (Kong, Levine and Smith, 1963). 
It seems apparent that induced immunity to fungal 
diseases is strongly influenced by the morphological 
attributes of the vaccine preparation, as well as the 
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routes of vaccination and of challenge. As is evident in 
Table 1 there has been general agreement that 1 ive H. 
capsulatum is effective in immunizing animals to subsequent 
challenge. Agreement concerning the efficacy of 1 ive 
vaccines by different investigators does not extend to 
killed vaccines. Reasons for discrepancies observed with 
killed vaccines or immunogenic extracts may include variables 
which become highly critical with killed vaccine or extracts. 
Resistance to infection with H. capsulatum can be induced 
in experimental animals by sublethal infection or by immuni-
zation with killed yeast phase cells or polysaccharides 
derived from these cells. Marcus and Rambo (1952) reported 
on the determination of LD50 values for yeast phase cells 
injected intravenously and noted differences in virulence 
of two strains of ~. capsulatum by this technique. They also 
reported that animals infected with a sublethal number of 
yeast phase cells became resistant to subsequent challenge 
with lethal numbers of organisms. 
Salvin (1953) demonstrated a method for obtaining con-
stant death rates in white Swiss mice. Various routes of 
inoculation were examined by infecting mice with live cells, 
Intracerebral inoculation seemed most successful in producing 
Table 1 
Induced immunity to Histoplasma ca~sulatum: 
Summary of findings on vaccination and cha lenge routes and 






Phase Host nation lenge Resistance Reference 
Route Route 
Yeast Mice i cer"i'\" icer Strong Salvin 1955 
i p"i'{' icer Strong Salvin 1955 
ip Increas Schaefer et al. 1954 
iv Increased Rambo & Marcus 1955 
Salfelder 1964 
i V"i~ icer Strong Salvin 1955 
iv Increased Hi 11 & Marcus 1959 
Rambo & Marcus 1955 
Row 1 ey et a 1 . 1956 
sc"{' icer Strong Salvin 1955 
Live Mycel i al Mice it r"i'{' itr Increased Farrell et a 1 ~ 1953 
Kil led Yeast Mice icer icer increased Salvin 1953 
ip icer Strong Salvin 1953 
ip Increased Schaefer et al. 1954 
iv Increased Hi 11 & Marcus 1959 
inc r. Rowley & Huber 1956 
iv Increased Hi 11 & Marcus 1959 
iv icer Strong Salvin 1953 
iv increased Hi 11 & Marcus 1959 
No inc r. Rowley & Huber 1956 
sc icer Strong Salvin 1953 
iv Increased Hill & Marcus 1959 fp,,;l{' icer Strong Salvin 1953 
oral icer Increased Salvin 1953 
iv No inc I 0 Hi 11 & Marcus 1959 
';t icer :::: intracerebral sc subcutaneous im = intramuscular 
ip intr ritoneal itr :::: intratracheal fp = foot pad 
v :::: intravenou:; 
N 
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constant death rates. A total of 220 mice were inoculated 
intracerebrally with yeast phase cells in physiologic 
sal ine~ The average LD50 at 21 days was determined in three 
separate experiments to be 3.0 x 104 organisms for H. 
1atum strain 6515. 
Immunization of mice for short periods of time was 
accomp1 ished by intraperitoneal inoculation with 5 mg of 
acetone-dried yeast phase cells, the broth filtrate from the 
mycel ial growth, or the broth filtrate from the growth of 
the yeast phase cells. Subsequent intracerebral challenge 
revealed protection against 300-400 LD50 of the fungus. 
S eve r ali mm un i z at i on r ou t e s ~ i n t rap e r ito n e a 1, i n t r a ve no us, 
and subcutaneous, were effective. 
Salvin (1955a) demonstrated that mice immunized with 
acetone-dried yeast phase cells had less infected tissues 
(spleen, 1 iver and kidney) than non-immunized mice. The 
presence of the fungus in tissues was determined by tissue 
section. The difference between the two groups was most 
noticeable during the first three weeks after intracerebral 
challenge with a lethal dose of yeast phase cells. In non-
immunized mice very rapid growth of the fungus occurred 
during the first few hours after chal1enge 9 and then a slow 
and gradual decrease in numbers of yeast phase cells occurred 
in the tissue cells during the next few months. Immunization 
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was relative in that it tended merely to lower the number 
of cells in various tissues. 
Resistance to reinfection in experimental histoplas-
mosis was shown by Salvin (1955b)o Mice previously infected 
with H. capsulatum were found to be more resistant to 
subsequent intracerebral challenge than normal mice. This 
resistance was manifested by a decrease in death rate, In 
mice that developed resistance after a sublethal intra-
peritoneal inoculation, subsequent intraperitoneal challenge 
resulted in the greatest number of fungus cells developing 
in the spleen, 1 iver, and at the site of injection. In 
intracerebral1y challenged mice which were immunized by a 
sublethal intracerebral injection, the fungus cells occurred 
in the 1 iver~ spleen, and brain. In control animals after 
intracerebral chal1enge 9 the organisms were found in lungs 
and kidney, In general, previous in tion tended to inhibit 
the growth of the fungus in the sp1een g 1 iver, and at the 
site of inoculation. 
Rowley and Huber (1956) studied the growth of H. capsu-
1 a um in norma 1, II supe r i n fec ted
'
! (recha 1 1 enge of in fec ted 
animals), and immunized mice. Chronic infections were 
produced in mice by injections of small numbers of viable 
yeast phase cells, approximately 70 aggregates. These mice 
were resistant to the lethal ef ts of 106 aggregates 
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injected intravenously. Growth of the fungus was inhibited 
in superinfected mice whereas in controls 9 after initial 
rapid multipl ication, there was a progressive decl ine in 
the number of viable organisms in the tissues. Mice 
immunized with a killed yeast phase cel 1 vaccine~ 109 cel Is 
given intraperitoneal ly or 108 cells given intravenously} 
failed to show any effect on the growth of Ho capsulatum in 
tissues. It was apparent that immunization with kil led 
yeast phase cells did not inhibit growth of the fungus in 
the 1 iver and spleen after intravenous challenge of 80 cells, 
Survival of Ho capsulatum in experimental histoplasmosis 
was demonstrated by Saslaw and Schaefer (1956). Mice were 
immunized and challenged by the intraperitoneal route of 
injection. The fungus was recovered frequently from the 
reticuloendothel ial tissues as late as 45 weeks after infection. 
Mice surviving previous sublethal challenge or those pre-
viously given one dose of heat-killed organisms showed 1 ittle 
variation. The only difference observed was a greater number 
of positive organ cultures in the sublethal group between 
16 and 30 weeks. 
Hill and Marcus (1959) studied the quantitative aspects 
of resistance induced against H. capsulatumo Using the 
intravenous route, LD50 determinations were studied using 
the yeast phase of the fungus. Strains exhibiting low and 
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high virulence were found Groups of mice were immunized 
by intraperitoneal injection of formal in-kil led yeast cells 
of each strain. The animals were challenged intravenously 
with varying numbers of yeast phase cells of the high viru~ 
lence strain. Either strain of the fungus was as effective 
as the other in immunization when compared to non-immunized 
control animals. The effect of route of immunization using 
either subcutaneous, intramuscular~ intraperitoneal or 
intravenous routes was studied. It was found that similar 
resistance levels were achieved by each route. Infection-
immunity was studied for its effect upon subsequent challenge. 
The group that was sublethally infected showed the same type 
of dose-dependent mortal ity relationship that was observed 
in the other groups of immunized animals. 
An important consideration was the dose of vaccine. 
The extent of immunity induced by kil led yeast phase Ho 
capsulatum was found to be dose-dependent (Schaefer and 
Saslaw, 1954; Salvin~ 1955) and at high doses the extent 
of resistance was comparable to that fol lowing sublethal 
infection (Saslaw and Schaefer, 1954; Salvin t 1955b; Hill 
and Marcus, 1959). Using 1 ive organisms the immune response 
to~. capsulatum was found to be dose-dependent (Salvin 9 
1955a). Although the dependency was less pronounced than 
with killed organisms, the presence of the immune response 
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demonstrated that strong stimulation occurred only after a 
threshold of immunogens was attained. Speculations concerning 
the high immunogenicity of 1 ive organisms have been discussed 
by Salvin (1960). One speculation is that the 1 ive organisms 
multiply and thereby increase their immunogen content in 
the host. Such mu1tip1 ication was evident after sublethal 
infection with Histoplasma (Rambo and Marcus~ 1954; Hill and 
Marcus, 1959). 
Resistance evoked by 1 ive organisms was 1 ittle influenced 
by the parenteral immunization route used (Table 1). The 
vaccination route appeared to be of major importance in fungal 
immunity induced by non1 iving vaccines. Aside from varia-
tions in the virulence of fungus strains (Drouhet and 
Schwarz j 1956; Howell and Kipkie, 1950) it is well documented 
that the capacity of a given strain to kill animals varies 
with the route of in ction and with the host. The LD50 of 
~. capsulatum for mice increases, in terms of numbers of 
or g ani s m s, w hen a dm i n i s t ere din the f 0 1 1 ow i n g 0 r d e r : i n t r a -
cerebrally, intravenously, intraperitoneally (Salvin, 1955a), 
However, using the intramuscular, intraperitoneal, subcutaneous, 
and intravenous routes for immunization~ Marcus and Hill 
(1959) found similar resistance achieved by each immunization 
route to subsequent intravenous challenge. In monkeys 
(Macaca mu1atta) intratrachael and intravenous injections of 
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~. capsulatum yeast phase appeared to produce a more severe 
dis e a set han t hat f 0 1 1 ow j n gin t ran a sal i n oc u 1 a t I on (S a slaw 
Carl isle and Sparks, 1960). In mice the intranasal route 
generally caused more severe histoplasmosis (Salvin} 1955a) 
than the intraperitoneal route Immunized mice showed a 
lowered resistance to respiratory challenge than to challenges 
by other routes (Grayston and Sal vin J 1956) 0 These workers 
found that mice given killed yeast cells of H. capsulatum 
showed less severe pathological changes after intracerebral 
challenge than after intranasal challenge, 
The foregoing reports indicate the importance of the 
challenge route in vaccine studies The intracerebral intra-
venous? and intraperitoneal routes generally al low the organ-
isms to disseminate rapidly to various organs~ whereas the 
respiratory route? in appropriate doses, initiates primarily 
a pulmonary disease (Grayston and Altman 9 1954; Procknow~ 
Page? and Loosl i? 1960) with extra-pulmonary dissemination 
as a later occurrence. 
It seems apparent from the reports concerning ~. capsulatum 
that immunity induced by 1 ive organisms persists longer than 
that induced by killed organisms. The duration of immunity 
evoked by 1 ive organisms may be attributed to prolonged 
stimulation provided by the persistence of the fungus in the 
host tissue (Salvin~ 1955a). Salvin (1955b) found that 
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resistance to histoplasmosis induced by alive vaccine was 
first detect when the mice were challenged three days 
after immunization and that it remained strong for at 
least 14 days, I mmu nit y f 0 1 1 ow i n g sub 1 e t hal i n t ion \tJas 
also effective against ~. capsu1atum (Schaefer and Sas1aw) 
1954) at 40 days and at 90 days (H ill and Marcus ~ 1959) 0 
However, with kil led vaccines 9 immunity to histoplasmosis 
decl ines over a relatively short period. Using a vaccine from 
yeast phase of Ho capsu1atum, Salvin (1955b) reported a 
decl ine with time, in resistance to intracerebral challenge. 
Mice were protected against a chal len of 320 LD50 adminis-
trated six to f6urteen days postvaccination but at 24 days 
they were protected only against 10 LD500 
IV. MANIFESTATION OF THE IMMUNE RESPONSE IN HISTOPLASMOSIS 
The most stringent tests of efficacy in experimental 
immunization are the prevention of overt in ctlon after 
challenge or the induction in the host of resistance 
sufficient to clear infection organisms without the develop-
ment of serious illness. Live yeast phase (Salvin~ 1955b) 
preparations have enabled animals to withstand severe 
challenge and to survive for extended periods. 
Suppressed growth of ~o capsulatum has also been 
reported in mice immunized with 1 ive or killed organisms 
and cha1len d intranasallY9 intraperitoneallY1 intravenouslY9 
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or intracerebrally, and in guinea pigs challenged intra-
peritoneally (Salvin, 1955a; 1955b)o Initially after challenge, 
mUltipl ication was most pronounced at the site of infection 
in both control and immunized mice j and the extent of brain 
and kidney involvement varied with the route of infection 
( Sal v i n 9 1 95 5 b ) 0 Grow tho f !:!. 0 cap s u 1 a tum 0 c cur s 1 a r gel y 
within cells of the reticuloendothel ial system and the 
organisms or lesions containing the organisms have been 
found invariably in the 1 iver and spleen regardless of the 
challenge route (Grayston and Altman, 1954; Grayston and 
Salvin, 1956; Larsh and Cozad, 1965; Procknow, Page? and 
L 00 s 1 i, 1 960; Sal v i n ~ 1 965 ) 0 Row 1 e y and Hub e r (1 956 ) 
indicated that growth of the organisms in tissues was 
inhibited in intravenously challenged mice only by the use 
of 1 ive cell vaccines. The six-day post challenge interval 
employed by Rowley might have been too short to detect low 
levels of inhibition. 
In the study by Grayston and Salvin (1956) brain 
involvement in control mice was extensive after intracerebral 
challenge, but there were only minimal inflammatory infil-
trates in mice vaccinated with 1 ive or kil led organisms. 
Oif rences in the 1 iver were less marked but granulomas 
were few and well organized in immunized mice. The spleens 
in both groups contained many organisms but few lesions. 
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The killed cell vaccine appeared to be less effective against 
intranasal challenge than against intracerebral challenge. 
Pathological involvement after int anasal challenge was 
1 imited and lung and 1 iver lesions in the control group 
were resolved spontaneously. 
Delayed dermal hypersensitivity reaction to H? capsulatum 
has been el icited in infected guinea pigs (Johnson and 
Scherago 9 1960; Knight and Marcus 1958; Marcus, Aoki ~ and 
H ill ~ 1 965 ), r a b bit s (M ark ow i t z ~ 1 964) j mo n key s (S a slaw J 
Carl isle? and Sparks, 1960) and rats (Okudaira and Schwartz} 
1962). Killed organisms or their fractions also were effective 
in sensitizing guinea pigs (Larsh 9 1960; Salvin, 1955a)n 
Because of the relative difficulty in skin testing in 
the mouse~ delayed hypersensitivity in this animal was tested 
by injecting histoplasmin either intravenously or into the 
foot pad. Early deaths in mice previously vaccinated with 
1 ive or killed ~o capsulatum were produced either by intra-
venous injection of organism (Box and Briggs~ 1961) or by 
intraperitoneal injection of organisms in mucin (SalvinJ 1958)0 
The state of hypersensitivity persisted for 14 months (Box 
and Briggs, 1961). 
v. I MMUNOGENS OF HIS OPLASMA CAPSULATUM 
The antigens which are protective in ~o capsulatum have 
been found in the cell wall. The yeast phase walls were as 
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immunogenic as killed whole cells and the protoplasmic 
fraction contained virtually no activity (Salvin and Ribi 
1955). The cell wall of the dimorphic fungus contains 1 ipids j 
polysaccharides, proteins, and chitin-l ike substances (Blank~ 
1954; Pine, Boone, and McLaughl in!t 1966)0 It is presumed 
to be the locus of protective and serologically active 
antigens in the yeast phase of the organism. 
Salvin and Smith (1959) isolated a protein-carbohydrate 
complex from culture filtrates of autolyzed yeast phase 
Histoplasma cells and it was as immunogenic as kil led cells, 
In contrast, the protective capacity of a predominantly poly-
saccharide-containing preparation used by Knight, Hill and 
Marcus (1959) was inferior to that of kil led cells. The two 
findings were not necessarily contradictory; neither the 
isolation and purification procedures were the same nor were 
the immunization and challenge regimens similaro 
The specificity of immunity induced by ~o capsulatum 
has been examined by cross challenge both with heterologous 
organisms having antigens in common and with those not so 
constituted. Live yeast phase H. capsulatum increased 
resistance against challenge with Blastomyces dermatitidis 
(Salfelder and Schwartz, 1964) in miceo Kil led yeast cells 
increased resistance to Candida albicans challenge (Hasen-
clever and Mitchell 1963)0 Hedgecock (1961) found that 
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immunization with a vaccine prepared from the mycel ial phase 
of H. capsulatum increased resistance to challenge by 
Mycobacterium tuberculosis. Induced immunity is not strain-
specific in experimental histoplasmosis (Hill and Marcus 
1 959; R amb 0 51 Mar c us, and Gun n, 1 955 ) 0 
VI MECHANISMS OF THE IMMUNE RESPONSE TO HISTOPLASMA CAPSULATUM 
Mechanisms and development of immunity to the mycoses 
have received 1 itt1e study. The significance of antihisto-
plasma antibodies in resistance is still obscureo Such 
antibodies conferred no passive protection on recipient mice 
(Rowley and Huber, 1956; Salvin, 1960). The importance of 
a cellular role in immunity to H. capsu1atum was demonstrated 
by accelerated infiltration of inflammatory cells and 
associated development of granulomatous lesions (Grayston 
and Salvin, 1956). 
Concerning the role of phagocytosis in immunity with 
H. capsulatum, an intracellular organism~ contradictory 
results have been reported. In one study~ the extent of 
fungal growth in macrophages from vaccinated mice was the 
same as that in macrophages from control mice (Howard, 1965). 
I not her stu die s 1 ( H ill and Mar c u s 1 1 960) p rio r i mm un i z a t j on 
increased the digestive capacity of macrophages (Miya and 
Marcus, 1961; Wu and Marcus, 1963). 
Studies in animals designed to elucidate the patho-
33 
genesis of Ho capsulatum infection and to develop potent 
vaccines have been hampered by intrinsic and extrinsic 
factors. The hazards involved in handl ing this pathogenic 
spore-forming fungus, and its morphological variabil ity 
present difficulties in experimentationo Nevertheless, 
inroads into the understanding of fungal immunity have been 
made; enhanced resistance to the fungus has been achieved 
by immunization. Also the site of the immunogenic substance(s) 
appears to have been local ized in the yeast phase cell wall? 
Immunomycology has received less attention than viral and 
bacterial immunology. However j as epidemiological and 
ecological knowledge expands~ publ ic health statistics point 
increasingly to the desirabil ity of fungal vaccines, especially 
in regions of endemic systemic mycotic disease. 
MATERIALS AND METHODS 
I 0 ORGAN ISMS 
Cultures of Ho capsulatum in the yeast phase were 
maintained at 37 0 C on antibiotic human blood agar, These 
were transferred at weekly intervals. 
Mycel ial cultures of ~o capsulatum were maintained at 
room temperature on SabouraudBs dextrose agar and were 
transferred every three to six months. Strains were also 
maintained under sterile mineral oilo 
Table 2 1 ists the twenty-three strains of H. capsulatum 
used in these studies and indicates the origin of the culture" 
These strains were originally isolated from human and animal 
sources j and from soil samples 
The yeast phase of the strains of the fungus were 
obtained by J...!l vitro or i.!l vivo conversion of mycel ial elements, 
In vitro conversions were obtained by transferring mycel ial 
elements onto blood agar slants containing antibiotics and 
after incubation at 37 0 C. Close-growing moist mycel ial 
colonies developed which were transferred until the yeast 
phase appeared. Mice were injected either intraperitoneally 
or intravenously with a sal ine suspension of the mycel ial 
elements to obtain ~ vivo conversion. The mice were 
autopsied at the end of two and four weeks and specimens 
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Table 2 
Origin of stock cultures of Histoplasma capsulatum 
Strain Strain 
number Or i gin number Origin 
21 71 a human, undated 3072 a human~ undated 
2247 human, undated 3154 from India, 1965 
2584 human, 1957 3289 human? 1965 
2585 so i 1 , 1957 3321 human, 1965 
2586 human, 1954 3330 human j 1965 
2645 human, 1957 G10 b human, 1949 
2779 from Japan, 1957 G56 var a duboisi, 
2813 human, undated G72 human, 1959 
2870 mouse, undated G75 human, 1960 
2888 human, undated 6651 .~ human, undated 
3014 so i 1 , 1960 G17M human j 1955 
3021 opossum, 1960 
obtained from Dr. N. F. Conant, Duke University 
obtained from Dr. C. Campbe1 1, Harvard University 





d obtained from University of Utah stock culture collection 
from 1 iver 1 lung, and spleen inoculated onto antibiotic 
blood agar plates. The resulting yeast phase organisms 
were then transferred onto blood agar slants. 
I I. MICE 
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Adult albino mice (Mus musculus) of mixed sexes, obtained 
from local sources were used in all experiments. Mice were 
maintained on Purina Laboratory Chow or Rockland mouse dieto 
I I I. MEDIA 
All cultures were grown and maintained on one of the 
f 0 1 1 ow i n g me d i a: 
Liquid. Yeast phase organisms for vaccine production 
were grown in the fo 11 ow i ng 1 iquid culture medium ( Hil1 9 1958) . 
Tryptose phosphate broth (Difco) 29.4 g 
Yeast extract 4 0 0 g 
Maltose 10 0 0 g 
Cystine 005 mg 
Distilled water 1000 ml 
Sol id~ The medium used for in vitro conversion 1 
maintenance and plate counts was antibiotic blood agar (Hill 
and Marcus, 1959). 
Tryptose phosphate broth (Difco) 29.5 g 
Agar (Difco) 20.0 g 
Human blood 15-20% 
Distil led water 800 m1 
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A final concentration of 25-50 units of penicill in and 
25-50 ~g of streptomycin per ml of medium were added. 
The medium used for maintenance of the stock culture was 
Sabouraud's dextrose agar (Ajell0, Georg, Kaplan, and 










Five media were employed in studying the sporulation 
characteristics and colony appearance. 
Modified Sauton1s medium (Will is and Cummings~ 1952). 
Dextrose 50.0 9 
Asparagine 4.0 9 
Citric acid 2.0 9 
G 1 yce r i n 50.0 9 
KH2P04 3H20 0.5 9 
MgS04 7H20 0.5 9 
NH4 ferric citrate 0005g 
Agar 20 9 
Dis tilled water 1000 ml 
F i na 1 pH of 704. 
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The fol lowing three synthetic media were modified after 
Artis and Baum (1963). 
Synthetic Medium One 
Dextrose 10.0 9 
KH2P04 1,5 9 
MgS04 · 7H20 0,5 9 
CaC12 . 2H20 0.15g 
( NH 4)2 S04 2,0 9 
Agar 20.0 9 
D i st ill ed water 1000 ml 
Synthetic Medium Two 
Medium two was identical to one except 2 9 of asparagine 
was substituted for the (NH4)2S04. 
Synthetic Medium Three 
Medium three was identical to medium one except for the 
(NH4)2S04 which was excluded. 
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A final pH after steril ization of 7 2 was obtained in 
these synthetic media. 
IV. LDSO DETERMINATIONS 
Animals were injected intravenously with 0.5 ml of the 
yeast cell suspensions. The organisms used were grown at 
370 C upon antibiotic blood agar The inoculum was prepared 
by suspending the organisms in 1% tryptose phosphate broth 
(Difco) in OQ9% NaCl (PSS). After aseptically filtering 
through glass wool, total numbers of cells were estimated 
from counts made in a hemocytometerQ Aggregates of yeast 
phase cells were counted as one. The concentration of the 
yeast phase organisms was adjusted with 1% tryptose phosphate 
broth so that each dose of organism was injected intravenously 
in 0.5 ml volume. The mortal ity ratio results after 30 days 
were analyzed by the use of either the method of Miller and 
Tainter (1944) or the method of Litchfield and Wilcoxon (1949). 
V. STRAIN DESCRIPTION 
Twenty-three strains of.!::!.o capsulatum maintained on 
Sabouraud's dextrose agar in the mycel ial phase were described 
as to their macroscopic appearanceo The media employed were: 
modified Sauton's medium, Sabouraud's medium containing 
phosphate ion, and synthetic media l? 29 and 3, The nitrogen 
source was asparagine in Sauton's medium, peptone in 
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Sabouraudls medium, and (NH4)2S04 in synthetic medium 1 ~ 
asparagine in synthetic 2, and no added nitrogen in synthetic 
medium 3. 
Plates were poured from each agar medium and inoculated 
with mycel ial elementso The plates were sealed with parafilm 
and incubated at room temperature. The plates were observed 
frequently for contamination as well as type of growth? 
Af te r 10 weeks of growth the cu 1 tu res we re k ill ed by exposu re 
to formaldehyde fumes for 2-7 days at room temperature, This 
procedure killed all cells as demonstrated by failure to 
multiply on Sabouraud's agar. The macroscopic appearance of 
the colonies was described in mycological nomenclature and 
documented with photographso 
VI. SPORE MEASUREMENTS 
Microscope sl ides were made of each strain grown on 
each medium The preparations were observed for the pro-
duct ion of microconidial and macroconidial spore types? 
The method of preparation of the microscope sl ides was based 
on a procedure described by Oro N. F. Conant (personal 
comm un i cat i on) . Api e ce 0 f t ran spa r en t II S tic k y tap e II was 
cut to fit under a coversl ip. The sticky tape was then 
pressed against the formal in-killed growth of the funguso 
The tape was removed with the spores and hyphal elements 
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adhering and placed sticky side up onto a microscope 
sl ideo Lacto-phenol cotton blue was dropped onto the tape 
and the coversl ip appl ied. The preparation was pressed with 
the eraser end of a pencil to remove any trapped air bubbles 
from beneath the coversl ip. 
Lacto-phenol cotton blue mounting fluid was prepared 
according to the following formulation: (Ajell0 9 Georg, 
Kaplan, and Kaufman 9 1963). 
Phenol crystals 
Lactic acid 
G 1 yce r i n 







The diameters of the microconidia and of the macro-
conidia were measured using an ocular micrometer. The 
diameter was measured from cell wall surface to surface not 
including the tuberculations of either spore type. The 
ocular micrometer was standardized for the optics of the 
microscope in use in this laboratory using a stage 
micrometer. Spore sizes are averages of six to ten measurements. 
The relative numbers of the spores were determined o 
A numerical rating was employed as follows: none observed 
(0), rare (1), few (2), and numerous (3)0 "None observed" 
is self explanatory. The sl ides were observed for two to 
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five minutes using the low power objective (total magnifi-
cation, 60X) for macroconidia, and then the high dry 
objective (total magnification, 264X) for macroconidia o 
IrRare" means the spores were difficult to find; only by 
moving to various oil immersion fields (total magnification, 
600X) were any observed. II Few" is defined as observing one 
field in which one or two spores could be found. "Numerous" 
is defined as more than two spores per observed oil immersion 
field. 
Using this rating system, a number was calculated to 
represent macroconidial and microconidial spore production 
in the various media. A ratio of macroconidia to microconidia 
was determined for each strain on the five media. 
VI I. VACCINE PREPARATION 
Strains of H. capsu1atum were grown in the mycel ial 
phase of Sabouraud's dextrose agar containing phsophate ion? 
After 10 weeks of growth the cultures were killed by exposure 
to formaldehyde fumes a~ described previously. The mycel ial 
grow t h was r emov e d as e p t i ca 1 1 y by s c rap i n g t he colon y sur -, 
face with a scalpel after covering the surface of the large 
p 1 a s tic pet rid ish e s (1 5 0 x 1 5 mm) wit h sal i n e con t a i n i n g 
0.1% Tween 80. The resulting suspension, composed of spores 
and mycel ial elements~ was concentrated by centrifugation 
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(800 x g) and then washed in sal ine solution. After the 
final wash, the spores and mycel ial elements were suspended 
in sal ine. 
Yeast phase suspensions of the organisms were grown 
in 1 iquid culture medium. One hundred ml of med um was 
placed in 500 ml Erlenmeyer flasks. Suspensions of yeast 
phase organisms grown on antibiotic blood agar were used 
as inocula o The cultures were incubated at 370 C until 
maximum growth was obtained (3-7 days) The flasks were 
agitated by a mechanical platform shaker (16 rpm) during 
the incubation period. Formal in was added to a final 
concentration of 0.5% and the flasks were kept at 370 C 
overnight. This procedure killed all cells as demonstrated 
by culture on antibiotic blood agar. The cells were concen-
trated by centrifugation (800 X g) and then washed in sal ine, 
After the final wash the cells were suspended in sal ine, 
After the final wash, the suspension of yeast phase 
or mycel ia1 phase cells in sal ine was transferred to a 450 
ml solution bottle (3" x 7" diameter, height) containing 
numerous glass marbles (16 mm diameter) and stainless steel 
balls (10 mm and 6 mm diameters). The bottle was then 
placed upon revolving rollers. The ball mill was al lowed 
to run continuously for 48 hours (myce1 ia1 phase) or 168 
hours (yeast phase) in the refrigerator (ca. 50 C) 0 After 
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grinding the cellular debris was removed by centrifugation 
at low speed (400-500 X g) and the supernate fluid employed 
as vaccine (designated a cell free extract). 
Macroconidia were separated from the mycel ium and 
m.icroconidia using a floation method (Stewart and Meyer, 
1932)0 The spores and hyphal elements were removed after 
covering the surface of the petri dish with sterile distil led 
water. The surface was scraped 1 ightly with a scalpel. The 
suspension was removed and pipetted into a large glass tube 
(7 3/4" x 1 1/4"). The upper layer was removed after a 20 
minute settl ing period, The procedure was repeated twice 
to further remove the mycel ium and microconidia from macro-
conidia. 
The vaccine preparations were weighed by pipetting 1,0 
ml of each preparation onto tared steel planchetso Three 
al iquots of each vaccine preparation were dried in an oven 
at 870 C until constant weight was reached. After the dry 
weights were obtaine~ appropriate dilutions were made for 
immunization procedures. 
VI I I. TESTS USED TO CHARACTERIZE VACCINES 
The vaccine preparations were tested for nitrogen and 
total hexose concentration. The methods were found in Kabat 
and Mayer (1962) and will only be summarized. 
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Estimation of protein with Fol in-Ciocalteu phenol reagent 
The method used is a modification for the estimation 
of 10-100 ug of nitrogen. The error reported for repeated 
determinations is about! 1 ~g nitrogen. 
Reagents: 
1. Folin reagent (Fisher Scientific Coo). 
2. 12.5% solution of Na2C03 (anhydrous). 
3. 0.1% solution of CuS04 . 5H20. 
Procedure: 
Two ml of solut ion were measured into a tube. Six ml 
of the Na2C03 solution and 100 ml of the CUS04 solution were 
added, mixed and allowed to stand for one hour at room 
temperature. One ml of 1:3 freshly diluted Fol in reagent 
was slowly added with constant mixing. After 20 to 30 minutes, 
the determinations (standard solution and unknown solutions) 
were read at 750 mu against a blank of 2 m1 of distilled water 
to which all the reagents had been added. The Coleman Model 
30 spectrophotometer was used. 
Anthrone reaction for total hexoses 
The reaction depended upon the formation of furfural 
derivatives and was best used in the range of carbohydrate 
from 50-250 ug. 
Reagent: 




Ten ml of anthrone reagent were pipetted into test 
tubes in a water bath at 10-15 0 C. The sample (5 ml) was 
carefully layered above the reagent. Blanks and standards 
of glucose were included. Each tube was agitated until 
mixed. The tubes were warmed to room temperature and heated 
at 900 C for 16 minutes, cooled and read in the Coleman Model 
30 spectrophotometer at 625 mUg 
I X. I MMUN I ZAT I ON 
Groups of mice were immunized by using the prepared 
formal in-kil led vaccines. Each animal received an intra-
peritoneal injection of 0.25 ml using various schedules as 
noted in the experiment. 
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EXPERIMENTAL RESULTS 
I. MACROSCOPIC APPEARANCE OF COLONIES 
Description of each strain of H. capsulatum on five 
different media grown at room temperature for 10 weeks is 
presented in detail. 
Each strain was described according to the following: 
1) Sabouraud's dextrose medium with phosphate ion, (Table 3); 
2) modified Sauton's medium, (Table 4); 3) modified Sauton1s 
medium without dextrose, (Table 5); 4) synthetic medium 1, 
(Table 6); and 5) synthetic medium 2, (Table 7). The 
macroscopic colonial characteristics were not described 
for synthetic media 3. Growth was scant on this medium which 
contained no added nitrogen source. 
Growth on synthetic medium 1 was similar to that obtained 
in synthetic medium 2. Sabouraud's and Sauton1s media both 
grew colonies differing in appearance. The nitrogen source 
in each medium was: 1) Sabouraud's, peptone; 2) Sauton's, 
asparagine; 3) synthetic 1, (NH4)2S04; and 4) synthetic 2j 
asparagine. The carbohydrate source in all of the media 
was dextrose. 
Sabouraud's and Sauton1s media supported best growth 
in these experiments. Synthetic 2 also supported good 
growth. On synthetic 1, synthetic 3 and Sauton1s without 
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Table 3 
Strains of Histoplasma capsulatum grown on 






Strain 2171 : 
Strain 2247: 
Strain 2584: 
for ten weeks 
colony flat, granular, with tan and white 
concentric rings. 
colony uniformly tan with concentric rings 
and lobate edges. 
colony cottony white and tan concentric rings. 
colony cottony, flat, tan with white variation 
colony white and cottony, flat, 
co 1 on y va rie gat B d w hit e and tan J f 1 a tan d 
cottony. 
entire colony tan, wooly, with concentric rings. 
colony center raised and folded, surface 
wooly, central color 1 ight tan, concentric 
ring of darker brown. 
Strain 2585: colony tan with powdery surface raised from 
agar surface and folded with numerous radial 
grooves o 
Strain 2586: entire colony heaped, glabrous ridges and 
powdery valleys. 
Strain 2645: colony flat, powdery, with cottony white 
peripheral growth and tan to brown center. 
Strain 2779: colony surface smooth and wooly with few 





Strain 3021 : 
Strain 3072: 
Table 3 (continued) 
colony center heaped, central area gray, 
edges tan to brown Q 
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colony center heaped with irregular folds, 
entire colony powdery and tan. 
colony cottony with heaped center, center 
gray, peripheral growth 1 ight tan. 
colony heaped and irregular folds, surface 
powdery, peripheral growth tan. 
colony dark tan, center raised and cottony, 
outside margin powdery. 
colony center heaped, periphery with irregular 
folds, color of center white to tan with 
edges tan and powdery. 
Strain 3154: colony gray with brown concentric rings, 
center heaped with many cracking ridges. 
Strain 3289: colony divided, one gray and cottony with 
ridges, the other tan and powdery with heaped 
and ridged areas. 
Strain 3321: entire colony heaped with irregular folds, 
colony uniformly gray and powdery. 
Strain 3330: colony center crateriform, edges with irregular 
folds, folds powdery white, colony center 
glabrous. 
Strain 6651: colony with white cottony center, peripheral 
growth white to tan, entire colony flat. 
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Table 4 
Strains of Histoplasma capsulatum grown on 
modified Sauton1s medium for ten weeks 
Strain G-10: colony with white powdery peripheral growth, 
surface at the center is glabrous, waxy with 
radial folds and steel-gray in coloro 
Strain G17M: colony crateriform with steel-gray center 
which is waxy and glabrous, peripheral growth 




Strain 2171 : 
Strain 2247: 
colony heaped with a white fluffy surface, 
colony white and powdery, center heaped and 
crateriform. 
no growth. 
colony with raised center with radial folds, 
color even throughout, surface tan and granular. 
colony heaped and irregularly folded, surface 
powdery to downy, center glabrous and steel-
gray with color following some of the radial 
grooves. 
Strain 2584: colony center cottony, concentric rings of 
g ray, ou t sid e r i n g w hit e, wit h mar gin p owd e r y 
and gray. 
Strain 2585: colony center raised and purple with peripheral 
growth gray with powdery appearance. 
Strain 2586: colony glabrous, center raised, color 1 ight 
brown. 
Strain 2645: colony powdery and granular with steel-gray 
glabrous center. 
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Table 4 (continued) 
Strain 2779: colony uniformly white, center raised with 
radiating ridges. 
Strain 2813: colony variegated brown and white, center 
raised, peripheral growth with dark brown 
concentric ring. 
Strain 2870: colony center grayish black with ridges, 
peripheral growth with brown concentric ring, 
Strain 2888: colony center heaped with ridges, dark gray 
in color, peripheral growth 1 ight gray, colony 
uniformly wooly. 
Strain 3014: colony center raised with numerous ridges, 
peripheral growth powdery and brown. 
Strain 3021: colony center raised and dark brown, outside 
margin gray and powdery. 
Strain 3154: colony center heaped and glabrous, dark brown 
in color, peripherally colony white radially 
furrowed and wooly. 
Strain 3321: colony center raised with many radial ridges, 
colony white to 1 ight gray except for con-
centric ring which is dark gray. 
Strain 3330: colony center brown and raised, edges powdery 
and white. 
Strain 6651: colony flat with folds, peripheral growth 
powdery to cottony, center raised, steel-gray 
and waxy_ 
Table 5 
Strains of Histoplasma capsulatum grown on 
modified Sauton1s medium without dextrose for 
ten weeks 
Strain G17M: colony uniformly gray and wooly_ 
Strain G-75: colony uniformly dark tan and powdery. 
Strain 21 71 : colony white with raised center. 
Strain 2584: colony uniformly tan and cottony. 
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Strain 2645: colony center raised and 1 i ght tan, peripheral 
growth brown. 
Strain 2870: colony grayish white and woo 1 y. 
Strain 2888: colony dark brown with 1 i ght tan concentric 
ring. 
Strain 3321: colony center raised and dark gray, peripheral 
growth grayish white. 














Strains of Histoplasma capsulatum grown on 











colony center sl ightly raised, entire colony 
glabrous and smooth, colony cream colored. 
colony center raised, surface cottony, color 
creamy. 
colony center elevated, surface cottony and 
whi teo 
colony center heaped and cracked, surface 
wooly and cream colored. 
colony white, raised center. 
colony gray, entire colony shallowly wrinkled. 
colony tan, entire colony deeply wrinkled. 
colony center raised, entire colony glabrous 
and dark tan. 
growth scant, tan and crusty. 
colony white with tan raised central area, 
crescent shaped tan surface area peripheral, 
remainder of colony wooly. 
Strain 2645: colony glabrous and smooth, tan in color, 
center raised. 










Strain 3321 : 
Strain 3330: 
Strain 6651 : 
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Table 6 (continued) 
colony center raised and 1 ight tan, colony 
cottony to powdery and 1 ight tan, 
colony white with raised center, cottony, 
colony center raised, glabrous, and gray, 
peripheral growth wooly and white. 
colony center crateriform, edges lobed} 
entire colony powdery and tan. 
colony center heaped, periphery wooly and 
1 i ght tan. 
colony center sl ight1y raised, entire colony 
wooly and 1 ight tan. 
colony center heaped, entire surface powdery 
and dark tan. 
colony glabrous and crusty, entire surface tana 
colony center heaped, uniformly gray and 
powdery. 
colony center raised 1 entirely white and 
powdery. 
colony whitish, raised center, glabrous margin. 
Table 7 
Strains of Histoplasma capsulatum grown on 
Synthetic medium 2 for ten weeks 
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Strain G-10: colony center white raised with furrows) 
peripheral growth scant, tan; and adherent. 
Strain G17M: colony center crateriform with radial furrows, 
growth white, peripheral growth tan and 
adherent. 
Strain G-56: colony white with patches of tan peripheral 
growth scant~ cottony. 
Strain G-72: colony whitish with diffuse tan throughout1 
raised center 1 radial grooves near periphery, 
growth generally granular. 
Strain G-75: colony uniformly white, with raised center} 
growth wooly. 
Strain 2171: colony variegated white and tan~ center raised 
and furrowed. 
Strain 2247: colony center gray-white, raised and furrowed} 
peripheral growth white and cottony. 
Strain 2584: colony uniformly grayish white, smooth and 
powdery. 
Strain 2585: colony center heaped~ and folds few and 
irregular, entire colony white and cottony. 
Strain 2586: colony center crateriform, edges glabrous, 
center powdery white 9 edges smooth and tan. 
Strain 2645: colony center crateriform, edges smooth and 
powdery, central colony dark tan, periphery 
1 ighter. 
Table 7 (continued) 
Strain 2779: colony tan with white concentric ring, 
uniformly powdery. 
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Strain 2813: colony center heaped, entire colony smooth~ 
powdery and 1 ight tan. 
Strain 2870: colony cottony, smooth and white. 
Strain 2888: colony with white central region with wide 
peripheral, band of center powdery, ba~ 
glabrous. 
Strain 3014: colony gray with 1 ight tan center, cottony and 
raised from agar surface 
Strain 3021: colony center heaped, and gl istening 1 
irregular folds to edges, entire colony white. 
Strain 3072: colony center heaped, powdery and white, 
peripheral growth tan and wooly. 
Strain 3154: colony center raised sl ightly, entire colony 
smooth and cottony, colony center 1 ight tan, 
edges dark tan. 
Strain 3289: entire colony dark tan, smooth and powdery. 
Strain 3321: colony center sl ightly heaped, central colony 
1 ight tan, edges tan and wooly. 
Strain 3330: colony center raised with few folds, center 
tan and powdery, edges white and cottony. 
Strain 6651: colony flat entirely white, with scant 
growth in peripheral areas. 
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dextrose the strains of Ho capsulatum grew poorly and after 
10 weeks, only covered the central area of the petri dishes. 
Figure 2 shows color photographs of macroscopic 
colonies of four strains of H. capsu1atum grown at room 
- . 
temperature for 10 weeks on Sabouraud's medium with phosphate 
ion. The strains shown are: G10~ G17M? G56, and 2779. 
I I. SPORE SIZE MEASUREMENTS 
Spore size measurements were made from observations on 
23 strains of ~. capsu1atum grown on Sabouraud's dextrose 
media with phosphate ion, modified Sautonis medium, and 
synthetic media 1, 2, and 3 (Table 8). Both macroconidia 
and microconidia were measured. The values were reported 
as averages for both of the spore types. The blanks in 
the table represent cultures which failed to grow or were 
contaminated. The zeros indicate that no spores were found 
of that type. 
The macroconidia1 and microconidial spores ranged in 
size from 6.5 - 14.3 u and 2.3 - 5.8 ~o The averages of 
the measured spores were: 1) Sabouraud's macroconidia, 
12.2 ~ and microconidia, 3.8 u; 2) Sauton's, 10.5 u and 
4.0 u; 3) synthetic 1, 9.4 u and 3.8 U; 4) synthetic 2? 
9.7 u and 3.2 ,u; and finally 5) synthetic 3? 10.9 ~ and 3.5 u. 
The largest macroconidia (12.2~) were formed on Sabouraud's 
Strain G10 Strain G17M 
Strain GS6 Strain 2779 
Figure 2. Four strains of Histoplasma capsulatum grown on Sabouraudls 






Histoplasma capsulatum macroconidia and 
microconidia spore sizes on five media 
Strain SAB C P04 Sauton1s #1 #2 #3 
No. Synthetic 
G10 - _ ... )( 9.8/0 10.9/0 9.5/0 
G17M 0/2.7 7.3/3.0 9.0/3.0 0/2.8 
G56 13.1/5. ]"i'o'\ 10.1/3.7 11.6/5.2 10.4/306 9.9/3.5 
G72 0/0 9.7/4.0 0/3.2 0/3.0 
G75 0/0 0/3.5 
2171 0/0 0/2.7 
2247 0/3.0 9.3/2.3 11 .6/3 10.6/3.2 
2586 0/0 0/4.7 0/2.3 0/0 
2585 11.8/0 10.0/4.2 9.1/4.3 0/3.5 8.3/3,3 
2585 0/0 0/0 0/3.7 0/0 0/0 
2645 14.3/4.5 8.9/3.8 8.5/4.9 12.6/5.7 
2779 10.7/3.1 12.8/0 12.0/4.2 9.3/3.0 9.0/4.0 
2813 12.1/4.0 10.5/5.8 9.8/2.7 9.1/2.9 11.7/4.5 
2870 11.0/0 0/0 0/0 0/0 11.0/4.3 
2888 0/0 0/0 9.1/3.8 0/0 0/0 
3014 0/3.5 0/0 10.4/5.0 0/0 12.0/0 
3021 12.0/3.0 10.3/4.5 9.3/4.3 0/0 14.2/3.8 
3072 13.5/5.7 9.5/4.0 10.5/4.9 0/3.5 9.7/2.9 
3154 10.2/0 12.5/3.8 10.5/3.7 11.0/3.1 10.0/.3.3 
3289 0/2.5 10.0/3.3 9.0/2.7 9.5/3.3 13.6/3.8 
3321 13.7/3" 1 8.5/0 6.5/2.9 9.3/2.7 0/3.3 
3330 0/3.8 11 • 1/0 0/3.7 0/3.0 0/2.7 
6651 7.0/4.5 8.5/2.8 0/3.2 
'k (data not obtained) 
'I','i~ macroconidia/microconidia, diameter i n microns 
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with phosphate ion. The largest microconidia were formed on 
Sautonis (4.0 ~). Mean sizes for microconidia on Sabouraud1s 
with phosphate and synthetic 1 were both 3.8 ~. 
The results shown in Figures 3, 4, and 5 were the 
average and the range of each spore size for each strain 
represented. Each point represents the macroconidial and 
microconidial spore size for each strain with the macro-
conidial size increasing along the abscissa. The results 
of spore size measurements of synthetic media l? 2~ and 3 
showed that no correlation existed between the size of the 
macroconidia and microconidia on synthetic media. 
I I I. RELATIVE NUMBERS OF SPORES 
Table 9 shows the relative numbers of macroconidia 
based on the rank system previously described. For each 
strain grown on each of the five media, the rank ratios given 
were for macroconidia over microconidia. Discarded cultures 
were indicated by blanks. 
The last column in the table shows a number which 
represented the sporulation character of the strains of H. 
capsulatum studied. A number above 1.00 indicated that the 
strain had produced large numbers of macroconidia, a number 
below 1.00 indicated that the microconidia predominated. A 
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Histoplasma capsu1atum relative numbers of 
macroconidia and microconidia on five media 
Strain SAB c P04 Sauton1s #1 #2 Sporulation 
No. Synt het i c numbe r"" 
media 
G10 3/3 a 3/3 2/0 3/0 1/0 2.00 
G17M 2/2 0/3 3/2 2/1 2/ 1 1 00 
G56 3/3 3/3 3/2 3/2 3/2 1 . 25 
G72 0/0 2/2 0/3 0/1 0.33 
G75 0/0 0/ 1 0/0 0/0 0.00 
2171 2/0 2/3 0/0 0/0 0/2 0.80 
2247 0/3 0/2 2/2 3/3 3/3 0.62 
2584 0/0 0/1 0/2 0/0 o 00 
2585 3/0 2/2 1/2 0/3 1/2 0.78 
2586 0/0 0/0 0/1 0/0 0/0 0.00 
2645 3/2 3/2 2/2 3/3 3/2 1.27 
2779 2/2 2/0 1/2 3/2 2/2 1 . 25 
2813 3/2 3/2 3/3 2/3 3/2 1 . 1 7 
2870 1/0 0/0 0/0 0/0 1/1 2.00 
2888 0/0 0/0 3/3 0/0 0/0 1.00 
3014 0/1 0/0 1/2 0/0 1/0 0.67 
3021 2/2 3/2 1/2 0/0 3/2 1 . 1 3 
3072 3/1 2/1 2/3 0/1 3/3 1 . 1 1 
3154 1/0 3/1 3/3 3/3 1 / 1 1 .38 
3289 0/3 3/1 2/3 3/2 3/1 1 . 1 0 
3321 3/2 2/0 2/3 1/3 0/2 0.80 
3330 0/1 1/0 0/2 0/1 0/1 0.20 
6651 2/3 2/3 1/2 3/2 0/2 0.67 
a macroconidia rank number/microconidia rank number 
-;'(' relative numbers of macroconidia to microconidia 
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number of macroconidia and microconidia. The figures for 
strain G10 served as an example for the calculations of the 
spore number: 
G10 










For the macroconidial number each numerator was added: 
3 + 3 + 2 + 3 + 1 = 12. Similar calculations determined 
the number for the microconidia, i.e. a denominator of six. 
The ratio, sum of the numerators over sum of the denominators, 
i.e., 12/6 or 2.00 was the sporulation number and was a 
relative measure of the type of spores produced by the straino 
The value did not give any indication of the abundance of 
spores produced. 
The data presented suggested that a correlation existed 
between nutritional properties of the media employed and 
sporulation abil ity. This is based on the following obser-
vations: two of 23 strains (G10 and 2870) produced a pre-
dominance of macroconidia as indicated by the sporulation 
number. However, the number of spores produced by G10 
was abundant on four of the five media, whereas strain 2870 
produced only scant numbers of spores on two of the five 
media. Two of 23 strains (G75 and 2586) produced only 
microconidia. Synthetic medium 1 yielded low numbers of 
microconidia from strains G75 and 2586, but no sporulation 
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occurred on the remainder of the media examined. Two of 23 
strains (G17M and 2888) produced an equal number of both 
spore types as indicated by the sporulation number. On 
Sautorls medium G17M did not produce macroconidia and on the 
remaining media the microconidia and macroconidia were 
produced in varying numberso Both (G17M and 2888) of these 
strains produced varying numbers or no spores on the media 
on which they were grown. Two strains (G72 and 3330) produced 
a greater number of microconidia than macroconidia, as 
indicated by the sporulation number. The remaining strains 
yielded sporulation numbers that varied between the two 
extremes (0.20-2.00). 
Although the sporulation number characterized the 
relation between total macroconidia and microconidia formed, 
it gave no estimate of the abundance of spores formed. For 
example, strain G10 formed only macroconidia on the synthetic 
media but the number of macroconidia formed falls into the 
classification "rare." On the other hand this strain forms 
equal and large numbers of both spore types on Sabouraud's 
medium with phosphateo 
Calculations were made similar to those described above 
but designed in this case to describe sporulation for each 
medium. The rank numbers of each strain on each medium 
were added, i.e. adding vertically in Table 9. Media which 
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supported best macroconidia1 or microconidial production 
could be determined using this method. Results are recorded 
in Table 10. 
The results suggested that the medium which supported 
the best macroconidial sporulation was Sabouraud's with 
phosphate. Synthetic media 1 and 2, and Sauton's medium 
supported better microconidial production, Synthetic medium 
3 supported formation of equal numbers of the two spore types. 
IV. VIRULENCE STUDIES 
In order to study the resistance of mice to infection 
with yeast phase~. capsu1atum~ it was desirable to know the 
virulence of selected strains and the effect that prolonged 
maintenance on artificial culture media had upon this 
virulence. Therefore, LD50 determinations were performed 
at various times throughout the course of this study. Data 
are presented in Table 11 which were obtained from LD50 
determinations of H. capsu1atum strain G17M, at different 
periods. Data in the table prior to 1956 were taken from 
Hill (1958). The virulence of this strain of H. capsulatum 
did not change significantly over a period of 15 years. 
Furthermore, other factors such as mouse passage, human 
passage, and conversion did not change the virulence of this 
strain. 
Table 10 
Media supporting the best sporulation of 
Histoplasma capsulatum 
Medium Sporulation 
Sabouraud's wi th phosphate ion 1 .30 
Modified Sauton1s 0.83 
Synthetic medium 0.79 
Synthetic medium 2 0.88 
Synthetic medium 3 1.00 
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Mouse LD50 determinations of yeast phase 







G17 M c) 
G17 M c) 
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Da 












1 • 1 x 1 06 
2.7 x 106 
9.0 x 105 
7.5 x 105 
1 .2 x 106 
6.5 x 105 
1.2 x 106 
5.0 x 105 
1 • 1 x 1 06 
6.4 x 105 
7.0 x 105 
(0.76 - 1.6 X 106 )+ 
( 1 . 0 - 7. 0 x 1 06 ) 
(0.35 - 2.3 x 106 ) 
(0.28 - 2.0 x 106 ) 
(0.66 - 2.2 x 106 ) 
(0.33 - 1.3 x 106 ) 
(0.80 - 1.8 x 106 ) 
(0.02 - 9.8 x 105 ) 
(0.92 - 1.3 x 106 ) 
(3.4 - 6.4 x 106 ) 
( O. 1 8 - 1. 2 x 1 06 ) 
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+ 
LD50 determined by method of Miller and Tainter (1944) 




conversion from mycel ial phase 
mouse passage, one/week for 15 weeks; determination 
at 5, 10, and 15 weeks 
after human passage 
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Strain 3154 of H. capsulatum was found to be of the 
same virulence for mice over an 18 month period. Table 12 
presents data obtained from LD50 determinations with this 
strain. 
Table 13 presents data obtained from virulence 
determinations on various strains of H. capsu1atum at different 
times throughout this study. The virulence of three of these 
strains (2645, 3330, and 6651) appeared to be similar. Strain 
2813 was the least virulent of the six strains that were 
studied. 
V. IMMUNIZATION 
Using the sporulation number as a basis for determining 
the morphological characteristics of a strain, four strains 
were chosen to represent the mycel ial phase of tl. capsulatum, 
(Table 14). Strain G17M was used as the source of yeast 
phase cells. 
Mycel ial phase cultures were grown on Sabouraud1s 
dextrose agar for 10 weeks at room temperature and harvested. 
The harvest from the cultures was placed in a ball mill 
and a cell free extract was prepared. The cell free extract 
was preserved with formal in and used as a vaccine. A whole 
macroconidial vaccine prepared with spores from strain G10 
was also used to immunize mice. 
Table 12 
Mouse LDSO determinations of yeast phase 
Histoplasma capsulatum strain 31S4 
Strain Date LDSO"k 
31S4 March, 1967 1 .4 x 104 
31S4 Octobe r, 1967 9.6 x lOS 
31S4 January, 1968 6.0 x 104 
31S4 Ap r i 1 , 1968 3.4 x lOS 
31S4 June, 1968 6.2 x lOS 
31S4 May, 1968 3.0 x lOS 
.,', 
LDSO and standard deviation determined by 
Miller and Tainter (1944) 
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Mouse LD50 determinations of yeast phase 
Histoplasma capsu1atum of various strains 
Strain Date 
2645 June, 1966 2.4 x 105 ::(2.0 x 
2645 December, 1967 7.6 x 105 :t(2,9 x 
2813 March, 1967 3.0 x 108 ~(4.3 x 
3330 Ap r i 1 , 1968 7.0 x 105 :±-(4.5 x 







,', lethal dose 50 :!" standard deviation after Miller and 







Strains of Histoplasma capsul atum 
util ized in immunity studies 
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Element produced SporulatIon number 
Macroconidia 2 D OO 
Mycel ium 0.00 
Mi'croconidia OD20 
Mixture of both spores 1.27 
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Yeast phase cultures were grown on 1 iquid medium and 
harvested after five days at 370 Co The cells were either 
pulverized in a ball mill or were left intact and util ized 
as a vaccine. 
All groups of mice in these reported experiments were 
immunized by intraperitoneal injection of either formal in-
killed cell free extracts or formal in-kil led whole cells. 
The doses of the challenging strain were also similar in 
each experiment, i.e., 1 x 105, 1 x 106 , and 1 x 10 7 popu-
lation units injected intravenously. 
After termination of each experiment the remaining mice 
were autopsied and the lungs were cultured on antibiotic 
blood agar. 
The data were analysed by the method of Litchfield and 
Wilcoxon (1949) and the LD50 and potency ratios are given 
in each experiment. 
In the first experiment (Table 15) the cell free 
extract prepared from strain G10 was used. The sporulation 
number for this strain of H. capsulatum indicated that the 
strain produced mainly macroconidia. Mice in one group 
received a 3 mg (dry weight) injection of the vaccine. Mice 
in the second group were injected with 2 mg. The third group 
of mice were injected with 1 mg. The control group was 
injected with sal ine (PSS). Ten days after the initial 
Table IS 
Vaccination of mice against histoplasmosis 
Mice vaccinated with formal in-kil led cell free extract of the 
mycel ium and macroconidia of GIO and challenged with 31S4 
30 day mortal ity ratios, per cent deaths, and culture results 
challenge 
dose PSS control 3 mg 2 mg 1 mq 
1 x lOS 1/9 11% a 0/10 0 0/10 0 0/11 a (6/8 7S%)b (1/10 10%) (1/10 10%) (2/11 18%) 
1 x 106 8/10 80% 0/10 0 0/10 0 1/10 10% (2/2 100%) (1/10 10%) (2/10 20%) (3/9 33%) 
1 x 107 10/10 100% 3/10 30% 0/10 0 1/10 10% (0/0 0 (4/7 S7%) (6/10 60%) (S/9 SS%) 
Totals 19/29 66% 3/30 10% 0/30 0 2/31 7% (8/10 80%) (6/27 22%) (9/30 30%) (10/29 3S%) 
4 .. 2 x lOS 1.3 x 107 7 6 LOSOc 1.0 x 10 6 
:±"(2.S x lOS) :±"(1.2 x 10 ) :(9.4 x 10 ) 
P.R. d 31 24 
(10-9S) (7-83) 
a mortality ratio and per cent deaths 
b culture positive lungs/total survivors 
c LOSO = lethal dose SO and standard deviation 




injections all mice were challenged intravenously with 
strain 3154. 
The results of immunization with G10, macroconidia1 
vaccine are shown in Table 15 and suggest that there was a 
difference between 3 mg and 1 mg in one injectiono The per 
cent deaths and culture results indicated no difference 
between the two groups immunized with either 2 mg or 1 mg. 
A lower frequency of culture positive lungs occurred in the 
group immunized with 3 mg. The potency ratio comparison 
between 3 mg and 1 mg was 31 and 24 respectively. 
The results in a second experiment involving immunization 
with G10 and challenge after 10 days with 3154 are shown in 
Table 16. The culture results indicated that as the dose of 
the challenge was increased the number of culture positive 
lungs increased. Although the total culture positive per-
centage was similar in the 0.8 mg and 0.4 mg groups, the 
potency ratio for 0.4 mg was 18.5 and the ratio for 0.1 mg 
was 5.0. 
Results in two experiments involving mice immunized with 
a cell free extract of the myce1 ium of G75 (a strain pro-
ducing no spores) are recorded in Tables 17 and 18. The 
sal ine controls for both experiments have equal LD50 values 
of 1.3 x 106 . The number of culture positive lungs for 
yeast phase growth, varied from 12% in the 0.8 mg group to 
Table 16 
Vaccination of mice against histoplasmosis 
Mice vaccinated with formal in-kil led cell free extract of the 
mycel ium and macroconidia of G10 and challenged with 3145 
30 day mortal ity ratios, per cent deaths, and culture results 
challenge 
dose PSS control 3 mg 2 mg 1 mq 
.-
1 x 105 1/8 13% a not done 0/8 0% 1/9 11% {3/7 43%)b (2/8 25%) (6/8 67%) 
1 x 106 3/8 38% not done 1/9 11 % 3/8 38% 
-
(4/5 90% ) (6/8 67%) (4/5 90%) 
1 x 10' 8/8 100% 1/5 20% 4/9 45% 6/10 60% 
COlO 0) (3/5 60%) ! (4/5 90%) (4/4 100%) 
Totals 12/24 50% {1/5 20% 5/26 38% 10/27 37% (7/12 58%) (3/5 60%) (12/21 57%) (14/17 38%) 
LD50c 7.0 x 105 1.3 x 107 3.5 x 10° 
::(4.0 x 105 ) 2-(1.6 x 107 ) ±(7.2 x 106 ) 
P.R. d 18.5 5.0 
(6-57) (1.6-15) 
a mortal ity ratio and per cent deaths 
b culture positive lungs/total survivors 
c LD50 = lethal dose 50 and standard deviation 




Vaccination of mice against histoplasmosis 
Mice vaccinated with formal in-kil led eel 1 free extract of the 
mycel ium of G75 and challenged with 3154 
30 day mortal ity ratios~ per cent deaths9 and culture results 
cha 11 enge 
PSS control 3 mg 2 mg 1 mg dose 
1 x 105 0/10 O%a 1/9 11 % 0/8 0°1 1/7 14% /f) 
(7/10 70%)b (0/8 O~) (1/8 13%) (2/6 ~~%) 
1 x 106 7/10 70% 1/9 11 % 0/8 ODIo 0/7 0% 
(3/3 100%) (1/8 13%) (0/8 0) (3/7 43%) 
1 x 107 8/10 80% 1/9 11% 1/7 14% 0/7 0% (2/2 100%) (5/8 63%) (4/6 67%) (6/7 86%) 
Totals 15/30 50% 3/27 11 % 1/23 4% 1/21 5% (12/15 80%) (6/24 25%) (5/22 23%) (11/20 55%) 
LD50 c 1 . 3 x 106 2.6 x 107 
:: ( 1 . 1 x 1 06 ) ~(1.6 x 107) 
P.R. d 20 
(7.6-53) 
a mortal ity ratio and per cent deaths 
b culture positive lungs/total survivors 
c LD50 ~ lethal dose 50 and standard deviation 
d potency ratio and 95 per cent confidence limits ........, (X) 
Table 18 
Vaccination of mice against histoplasmosis 
Mice vaccinated with formal in-killed cell free extract of the 
myce1 ium of G75 and challenged wIth 3154 
30 day mortal ity ratios, per cent deaths~ and culture results 
challenge 
PSS control 0.8 mg 0.4 mg 0.1 mg dose 
1 x 105 1/10 10% a 2/10 20% 0/7 O~o 0/8 0'0 (8/9 89%)b (0/8 07'0' (2/7 29%) (1/8 13%-) 
1 x 106 7/10 70% 0/11 0'-0 1/7 14% 1/8 13% 
(2/3 67%) (0 111 9%) (2/6 33%) (4/7 57%) 
1 x 107 7/10 70% 0/7 0'0 6/10 60% 4/10 40% 
(3/3 100%) (2/7 29%) (4/4 100%) (3/6 50%) 
Totals 15/30 50% 2/28 7% 7/24 29% 5/26 19% 
(13/15 87%) (3/26 12%) (8/17 47%) (8/21 38%) 
LD50 c 1 . 3 x 106 6.1 x 106 6 1.3 x 107 
-r(1.8 x 106 ) -- ::(6.5 x 10 ) ::(1.7 x 107) 
P~R. d 4.7 10 
-- (1,.3 18) _(1. 3= 43 )_ 
a mortal ity ratio and per cent deaths 
b culture positive lungsltotal survivors 
c LD50 = lethal dose 50 and standard deviation 
d potency ratio and 95 per cent confidence 1 imits '-l \...0 
80 
80% in the sal ine control group. The potency ratios are 
as follows: 2 mg, 20; 0.4 mg, 4.7; and 0.1 mg , 10. The 
injection of 2 mg of vaccine gave the highest protection 
based on the potency ratio. 
The cell free extract vaccine prepared from strain 
3330, was used to immunize mice and yielded the results 
shown in Table 19. The potency ratios were: 1 mg, 11.8; 
0.4 mg9 7.6 and 0.1 mg, 1.5. The culture results indicated 
that as the dose of the vaccine was increased the number of 
culture positive lungs decreased. 
Using the cell free extract of strain 2645, which 
yielded a mixture of both types of spores, as a vaccine the 
potency ratios were: 15.4 for 3 mg and 9.3 for 2 mg and 1 mg. 
The results are shown in Table 20. The total per cent 
culture positive lungs for each group were: controls, 42%; 
3 mg, 23%; 2 mg, 14%; and 1 mg, 31%. 
Vaccination of mice with the cell free extract prepared 
from the yeast phase of strain G17M gave results shown in 
Table 21. The potency ratios are: for 0.4 mg a value of 23 
and for 0.1 mg a value of 11.5. The culture result totals 
ranged from 11-92%. 
Mice immunized with whole cells of either macroconidia 
of strain G10 or yeast cells of G17M gave the results shown 
in Table 22. The potency ratio calculated for each group of 
Table 19 
V3ccination of mice against histoplasmosis 
Mice vaccinated with formal in~killed cell free extract of the 
mycel ium and microconidia of 3330 and chal1eng with 3 
30 day mortal ity ratios, per cent deaths, and culture results 
cna' 1 enge 
dose I PSS controll 2 mg 1 mg 004 mg 0.1 mg 
1 x 105 not done not done 0/7 14% 2/7 29% 
40o/n) 
1 x 106 5/7 72% 0/5 0% 




1 x 107 I 7/7 100% I 0/5 OPa I 2/9 22% I 4/8 50% J 7/8 (0/0 0~6) (1/5 20%) (4/7 57%) (3/4 75%) (1/1 88% 100%) 
ta1s 




4.6 x 105 5 
:±" x 10 ) 
0/10 O~a 
(3/10 30%) 
3/23 12% I 7/23 30% (3/20 40%) (6/16 37% 
5.4 x 106 , 305 x 106 
±(5.5 x 106~ ±(l Q3 xl06 ) 
11.8 I 7.6 (4.2-31) (NC) 
a mortal ity ratio and per cent deaths 
b culture positive lungs/total survivors 
c L050 = lethal dose 50 and standard deviation 
d potency ratio and 95 per cent confidence 1 imits 
12/23 52% 
(6/11 55%) 




T 1e 20 
Vaccination of mice against histoplasmosis 
Mice v3ccinated with formal in-kil led cell free extract of mycel ium 
and spores of 2645 and challenged with 3154 
cha 1 1 enge 
dose 
30 day mortal Ity ratio5~ per cent deaths, and culture results 
I 
1 x 105 
1 x 106 










( 1 /1 1 00%) 
18/30 60% 
L51J1_ 1.t2%) 
5.6 x 105 
± (5.9 x 105 J 
3 mg 











8.6 x 106 
:!"16.2 x 106 ) 
15.4 
(4.7-50) 
a mortal ity ratio and per cent deaths 










(0/9 o I 0/9 0';0 o (3/9 33%) 
7/10 
(2/3 '70% I 7/1 0 70% 67%1 (3/3 100%) 
7/29 24% 
(3/22 14%) 
5.2 x 106 





5,,2 x 106 
±(3.2 x 106 ) 
9.3 
(2a9-29) 
c LD50= lethal dose 50 and standard deviation 
d potency ratio and 95 per cent confidence 1 imits co N 
Table 21 
Vaccination of mice against histoplasmosis 
Mice vaccinated with formal in-ki1 led cell free extract of yeast 
phase G17M and challenged with 31S4 
30 day mortal ity ratios, per cent deaths, and culture results 
cha 11 enge 
PSS control 1 mg 004 mg dose 0.1 mg 
1 x lOS 1/8 13% a 0/9 O~ 0/8 0 0/9 0 
(7/7 100%)b (0/9 0%) (0/8 o ) (1/9 11%) 
1 x 106 3/8 38% 0/8 0'"'-"":';" 0/8 o ,", 1/8 13% 
(4/S 90%) (1/8 13%) (2/8 2S%) (2/7 28%) 
1 x 107 8/8 100% 0/8 0 1/8 13% 3/8 38% (0/0 oj:, ) (2/8 2S%) (6/8 67%) (3/S 60%) 
Totals 12/24 SO% 0/27 1/24 47% 4/2S 16% 
(11/12 92%) (3/27 11 %) (3/23 34%) (6/21 28%) 
LDSO c 7 x lOS 106 x 107 8.0 x 106 i"(4.4 x lOS) -- ::J 1 . 4 x 1 0 7 ) ~(9.4 x 106 ) 






a mortality ratio and per cent deaths 
b culture positive lungs/total survivors 
c LOSO = lethal dose SO and standard deviation 
d potency r3tio and 9S per cent confidence 1 imits 00 
w 
1 e 22 
Vaccination of mice against histoplasmosis 
Mice vaccin3ted with formal in-killed whole spores or yeast phase 
cells and challenged with 3154 
30 day mortal tty ratios, per cent deaths, and culture results 
challenge GlO Gl7M whole cells MacroconiSia dose PSS control 7 ~ x 10 106 cells 5 x 107 cells 
1 x 105 2/10 20% a 0/7 0 0/9 0 0/8 0 
(6/8 67%)b (5/7 71%) (4/9 45%) (4/8 50%) 
1 x 106 5/10 50% 3/8 38% 4/9 45% 1/7 14% 
(5/5 100%) (3/5 60%) (3/5 60%) (2/6 33%) 
1 x 107 9/10 90% 6/8 75% 3/9 33% 2/10 20% ( 1 /1 100%) (2/2 100%) (5/6 84%) (6/8 75%) 
Totals 16/30 53% 9/23 39% 7/27 25% 3/25 12% (12/14 86%) (10/14 72%) (12/20 60%) (12/22 55%) 
L050 c 7.0 x 105 6 204 x 106 6 8.0 x 106 
:!"(2.1 x 106 ) 5~0 x 10 6 ±-(809 x 106 ) !(1~7 x 10 ) ±(4.9 x 10 ) 
P.R" d 3~4 7.2 1 1 " 4 
-- (0.9-12.5) (2- 28) (206~51 ) 
a mortal ity ratio and per cent deaths 
b culture positive lungs/total survivors 
c L050 = lethal dose 50 and standa d deviation 




immunized mice were: G10 (7.3 x 104 cells), 3,4; G17M 
(1 x 106 ce 11 s), 7 g 2; and G 17M (5 x 107 ce 1 1 s) ~ 11 04) The 
culture results were similar: G10 macroconidia, 72%; G17M 
(1 x 106 ), 60%; and G17M (5 x 107), 55%, Eighty-six per 
cent of the sal ine controls were culture positiveo Results 
recorded in Table 23 show a summary of the potency ratios 
for the vaccines prepared from the various strains of Ho capsu-
latum o The results indicated that cell free extracts either 
of strain G10 (mycel ial phase) or of strain G17M (yeast 
phase) had similar potency ratios. The ratios are: G10 -
0.4 mg, 1 8 5; O. 1 mg, 5.0 and G 1 7M - 0 0 4 mg, 23; O. 1 mg, 1 1 05, 
for identical vaccine doses. Strains G75, 2645 1 and 3330 
cell free extract vaccines had potency ratios which varied 
from 1.5 to 20.0. The whole cell vaccines prepared from 
strains G17M and G10 had ratios between 3.4 and 11.4. 
Determinations of the chemical composition of the 
vaccines prepared from certain ~o capsulatum strains are 
shown in Table 24 Strains G10 and G17M have similar carbo-
hydrate-protein ratios of 57 and 56 respectively. The 
remaining vaccines had ratios that varied between 6 0 7 and 
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Table 23 
Comparison and summary of potency ratios of vaccines 
from various strains of Histoplasma capsulatum 
Amount a Potencyb 
Strain Injected Ratio Description 
3.0 mg 31.0 (10-95) myce 1 i a 1 phase 
1 0 mg 24.0 (7-83) CFE c 
0.4 mg 18? 5 (6-57) 
0.1 mg 5.0 (1.6-15) 
Gl0 
G75 2.0 mg 20.0 (7.6-53) myce 1 i a 1 phase 
0.4 mg 4.7 (1.3-18) CFE 
0.1 mg 10.0 (2.3-43) 
2645 3.0 mg 15.4 (4.7-50) myce 1 i a 1 phase 
2.0 mg 9.3 (2.9-29) CFE 
1 .0 mg 9.3 (2.9-29) 
1 . 0 mg 1 1 .8 (4.2-31) myce 1 i a 1 phase 
0.4 mg 7.6 (NC) a CFE 
0.1 mg 1 . 5 (0.43-5.2) 
3330 
0.4 mg 23.0 (7.8-69) yeast phase 
O. 1 mg 11.5 (3.6-38) CFE 
G17M 
106 (0.53 mg) 7.2 (2-28) formal inized 
5 x 107 (2.7 mg) 1 1 .4 (2.6-51 ) yeast cells 
G17M 
Gl0 7.3 x 104 3.4 (0.9-12.5) formal inized 
macroconidia 
a dry weight of suspension injected 
b potency ratio and 95% confidence 1 imits determined by 
Litchfield and Wilcoxon (1949) 
c CFE (ce 11 free ext ract) 
d not calculated 
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Table 24 
Chemical composition of five strains of 
Histoplasma capsulatum 
Vaccine 
%CHO a ) %Protein b ) Ratioc ) 
Dry 
Strain Description Weight 
G10 myce 1 i a 1 phase, 34% 0.6% 57.0 2308 mg 
CFE"'-
G75 myce 1 i a 1 phase, 47% 7.1% 6.7 6.3 mg 
CFE 
G17M yeast phase, 39% 0.7% 56.0 9.4 mg 
CFE 
2645 myce1 ia1 phase, 35% 2.9% 12.0 10.9 mg 
CFE 
3330 myce1 ia1 phase, 33% 4.4% 7 5 1701 mg 
CFE 
G17M yeast phase, 39% 3.2% 9. 1 10 0 5 mg 
whole cells 
* 
CFE (ce 11 free extract) 
. / 
a) ~arbohydrate (CHO) determined by anthrone method 
b) protein determined by Fo1 in and Cioca1teu method 
c) ratio % CHO/% protein 
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DISCUSSION 
H capsulatum is composed of a thallus which may be 
considered as both vegetative and reproductiveo The 
vegetative thallus is composed entirely of mycel ial filaments 
of hypha, which are generally branched and spread in all 
directions from which the spores arise. The reproductive 
part includes all structures which lead to the formation 
and dispersal of the various spore types. 
The extreme polymorphism of fungi is a major challenge 
to students of mycology. Doctors, veterinary surgeons, and 
cl inical laboratory and publ ic health workers famil iar with 
the 1 ife cycles of protozoa and helminths which are para-
sitic on man and animals will appreciate the significance 
of the range of fungal formso 
Morphological reduction in size associated with parasitism 
may be regarded as a particular case of fungal polymorphism 
(Lan ron and Vanbrueseghen, 1965). Thus, the fungal 
parasite, ~. capsu1atum, has a saprophytic stage composed 
of varied forms and a parasitic state which is yeast-1 ike, 
The occurrence of histoplasmosis in man and animals 
is related to the colonization of suitable natural substrates 
in the environment by histoplasma. Apparently, histoplas-
mosis is contracted by inhalation of spores after exposure 
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to the fungus growing in the environment. H. capsu1atum 
has been isolated from this environment which includes soil 
and debris from: chicken houses 9 caves~ hollow trees, 
barnyards 1 river bottoms including water human and animal 
tissues. Available laboratory specimens 9 identified as 
~. capsu1atum by observing typical macroconidia, have n 
given various strain designations by individuals who isolated 
the fungus. The designations range from letters and numbers 
to the name of the patient or locale of the isolateo 
Identification is currently based solely on morphology. 
This situation leads to some strange results. First, 
available isolates must always be identified as H. capsulatum 
after transfer to a new laboratory. This can be a tedious 
procedure when a relatively asporogenous strain is being 
investigated (ego~ G75). The current arbitrary designation 
of strains may be based on locale of isolation? in which 
case it is not clear whether the organism was isolated from 
soil ~ a lesion (human or animal) or fomites. Again9 strain 
designation may be based on whether the organism was isolated 
from a particular area, For example, one strain used in 
this study, 3154, is labeled "India." The origin of the 
strain is again unclear. 
The large number of strains each 1aboaratory maintains 
results in much cumbersome dup1 ication of effort. It must 
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be granted that 1 ittle is known out~. capsulatum~ and 
that some means for identifying strains of the fungus in 
terms of origin as well as species j must exist. The 
procedures used in the identification of pathogenic bacteria 
might well be fol lowed. The classification of pathogenic 
b act e ria fa 1 1 sin the f 0 1 1 ow i n g g e n era 1 g r 0 up i n g s: 1) 
morphology and staining, 2) cultural characteristics such 
as fermentation and pigment production~ 3) serology including 
antigenic structure, and 4) production of a disease process. 
A keystone in the classification of higher plants and 
animals is the definition of a species as a group of individ-
uals capable of continued fertile interbreeding (Davis et alo, 
1968). However, this keystone does not apply to bacteria 
and fungi for which the situation is quite different. The 
number of characteristics available which enable species 
identification for bacteria and fungi is 1 imited. There 
is no known example 'of ontogeny to rec itulate phylogeny; 
there is no fossil record; and finally, reproduction is 
ordinarily asexual a The definition of Davis, et al.? 1968, 
for species is therefore not usually fulfil led o The grouping 
of individual strains into the same kind or species is usually 
settled without benefit of the interfertility test. Moreover 
the mutabil ity and the rapid growth of these organisms? 
combined with strong selection pressures from changes in the 
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peptone, 2) modified Sauton1s contained asparagine, 3) 
synthetic 1 contained (NH4)2S04, 4) synthetic 2 contained 
asparagine and 5) synthetic 3 contained no nitrogen source, 
Sautonis and synthetic 2 contained the same nitrogen source, 
but macroscopically the colonies appeared dif rento 
Factors other than carbohydrate and nitrogen sources must 
playa role in the color and texture of the colonyo 
The mycel ial phase of ~o capsulatum grows well at 25 0 C 
on synthetic media having a single nitrogen source~ although 
some strains demonstrate individual amino acid requirements 
(Rowley and Pine, 1955). Of the carbohydrate sources 
dextrose gives optimal growth (Scheff~ 1945). The growth 
on synthetic 1 was less in comparison to growth on 
Sabouraud's and Sauton1s. Synthetic 3 supported growth 
which was scant, del icate and about the size of a dime, 
This latter medium contained no added nitrogen. The endo-
genous nitrogen present in the medium and the nitrogen 
present in the inoculum was apparently a 1 imiting growth 
factor o Growth on synthetic medium 2 was similar in size 
to growth on Sabouraud's with phsophate; however~ growth 
on synthetic 2 medium differed in color and textureo 
In addition to the differences noted above~ there are 
differences in the sporulation characteristics of each 
strain of Ho c sulatum and growth on the various media. 
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Apparently there are certain 1 imitations of interpretation 
with regard to the sporulation data due to the methods of 
study. It is probable that measurements made from colonies 
grown on media other than those studied might have given 
different results. It might also have been better to have 
emulsified the whole culture and then measured the numbers 
and sizes of the spores rather than selecting an arbitrary 
area as was done. It does not appear~ however, that these 
criticisms would 1 imit comparison between strains where 
all were treated in 1 ike manner. 
The measurements of the spore sizes suggest that there 
are differences among media which induce differences in 
spore sizes. For example, macroconidia grown on Sabouraud's 
with phosphate were larger than the spores observed in the 
remaining media employed in the study. Mycel ial phase 
cultures grown on Sauton1s medium produced microconidia 
which were larger than those formed on the other media. The 
difference in size of the macroconidia is more striking than 
is the difference in microconidial sizes on the six media 
util ized in this study. The figures showing the sizes of 
microconidia and macroconidia of different strains of 
~. capsulatum yielded no overlapping between the two spore 
types. However, these figures represent only three of the 
six media studied, i.e., synthetic media 1, 2, and 30 These 
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media contained similar constituents except for the additional 
nitrogen source or lack of nitrogen. Apparently there was 
a size difference in macroconidia formed on synthetic 1 
as compared to synthetic 3 media. Analysis of the remainder 
of the data yielded no additonal information. 
Although sporulation of ~. capsulatum is primarily a 
strain dependent phenomenon (Howel l, 1939), some investi-
gators have noted variation in degree of sporulation in 
supplemented media o For example, addition of phsophate ion 
to Sabouraud's medium (Artis and Baum, 1963) and variations 
of media containing different nitrogen or carbohydrate 
sources (Negroni, 1940) have been noted to enhance sporu-
lationo The data that have been presented in this thesis 
suggest that there is a correlation between nutritional 
properties and sporulation abil ity. 
The factor(s) or characteristic(s) of the culture media 
tested which contributed to the production of either macro-
conidia or microconidia were not examined. The enrichment 
of Sabouraud's medium with a source of phosphate such as 
KH ZP04 was reported by Artis and Baum (1963) as being useful 
in stimulating tuberculate spore production (macroconidia 
production). The results of their study demonstrated that 
tuberculate macroconidia are not in a resting or survival 
stage since depleted media and nutritionally poor media did 
not stimulate 
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ore production. Using calculations from 
the sporulation numbers, the Sabouraud's medium with additional 
phosphate ion supported relatively more macroconidia. Similar 
calculations suggested that the synthetic media 1 and 2, 
and modified Sauton1s medium produced relatively more 
microconidia. Synthetic medium 3 supported formation of 
approximately equal numbers of both spore typeso 
Smith and Furcolow (1964) suggested that the addition 
of an infusion of starl ing manure to soil has the effect 
of producing more total particles and of producing a large 
number of microconidia as well as increasing the viabi1 ity 
at least twice that observed in other media. Of particular 
interest was the finding that although large numbers of 
particles are produced on Sabouraud's medium, 84% of these 
particles are hyphal elements and not spores, but the 
overall viabil ity was only 3%. It is clear that some essen-
tial element(s) in the extract of bird manure augments the 
orulation potential of the organism in soil. However 1 
the presence of large amounts of extraneous materials makes 
the use of this medium undesirable for immunological work 
with the derived myce1 ial phase. 
Smith (1964) has reported that a medium composed of 
0.6% yeast extract and 2% agar in distilled water stimulated 
rapid growth and sporulation of H. capsulatum similar to 
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that of star1 ing manure extract medium. The rapid growth 
consisted of many viable microconidia and a low ratio of 
vegetative myce1 ium. These findings suggest that the spore-
stimulating substances are nutritional in nature. 
The results of sporulation experiments reported in this 
thesis support the premise that sporu]·ation is related to 
the nutritional environment on which the Ho capsu1atum is 
grown. The measurement of the abi1 ity of each strain to 
produce spores was based on microscopic appearance of the 
myce1 ium and spores. The measurement was relative and rank 
statistics were used in assigning a number value to a set of 
defined terms. Using this method the sporulation number 
of each strain on each medium was obtained. This sporulation 
number gives no indication of the abundance of the spores 
but only the abi1 ity of each strain to produce spores. The 
sporulation number was used to indicate the abi1 ity of a 
strain to produce spores and the type of spore for preparation 
of vaccines. Sabouraud's medium with phosphate ion was 
chosen as the medium upon which the mycel ia1 phase organisms 
were to be grown. This medium was chosen from among the 
media studied for the following reasons: 1) ease of prepar-
ation, 2) abundance of growth, and 3) abi1 ity to support 
spore production in abundant numbers. Harvest of the 
myce1 ia1 phase of H. capsu1atum occurred after 10 weeks. 
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This period was chosen because maximum growth and numerous 
spores were obtained at this time. 
Data from the experiments described in this thesis 
suggest that sporulation by H. capsulatum is dependent upon 
the strain of the organism and the medium on which it grows. 
Some strains will sporulate in such a manner that only well 
defined large macroconidia are produced (strain G10). Other 
strains, for example 3330 and 6651, formed large numbers of 
microconidia and few macroconidia. In many strains there is 
a marked size and morphological differentiation between 
microconidia and macroconidia. In a few strains the gradation 
of size of the spores progresses so smoothly from microconidia 
to macroconidia that no real distinction can be made between 
the two forms. 
A fundamental problem in medical mycology is the 
question of variation in virulence between strains of 
H. capsulatum. Drouhet and Schwarz (1956) and Howell and 
Kipkie (1950) have reporte these differences in strains 
of H. capsulatum. In only one available report (Rowley 
and Huber, 1955) has it been observed that different strains 
of this organism were not significantly different with 
regard to mouse virulence. Using methods described in this 
thesis, significant differences in virulence were noted 
among the tested strains of ~. capsulatum, i.e. an LD50 for 
strain 31S4 of 3.0 x lOS, an LDSO for strain G17M of 
1.1 x 106 , and for strain 2813 of 3.0 x 108 (Table 13). 
It can be recalled that yeast phase organisms of each 
strain were injected intravenously. These differences 
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in LDSO could be due to differences in the mouse virulence 
of the strains of organisms used but this difference might 
be unrelated to human disease. There was no morphological 
or physiological explanation apparent for the wide variance 
in mouse virulence observed with the different strains. 
The 23 strains of H. capsu1atum studied were isolated 
from human and animal sources, and from soils. The strains 
differed in myce1 ial phase morphology both in macroscopic 
colony appearance and in microscopic appearance. The yeast 
phase cells of the organisms observed were morphologically 
similar. 
Results showed that the virulence of strain G17M did 
not change to any significant degree when maintained in 
the yeast phase on antibiotic containing blood agar for long 
periods of time at a temperature of 370 C. Similar results 
were demonstrated with strain 31S4 but over a 1.S year time 
period as opposed to lS year period for G17M. Furthermore, 
other factors such as rapid passage on cultural medium, 
mouse passage, human passage, and conversion did not change 
the virulence of strain G17M. 
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The susceptibil ity of the mouse to infection by small 
doses of H. capsulatum, either spores or yeast phase? makes 
this host a significant one in which to study problems in 
! mm un i t Y ~ Let hal i n f e c t i on s wit h I n r e 1 at i vel y s h 0 r t per I od s 
are produced only by parenteral inoculation of 105 or more 
yeast phase organisms depending on the virulence of the 
s t r a i nus e d ~ Sin c e a m 0 r tal i t yen d po nth a s c e r' t a i n 
advantages, challenge doses of strain 3154 were employed 
with doses as great in magnitude as 107 organisms administered 
by the intravenous route, that is, about 100 LD50 doses. 
The strains of H. capsulatum ut,l ized in immunity studies 
were chosen because of the fol lowing characteristics: strain 
G10 produced abundant macroconidia on Sabouraud's medium 
with phosphate. Strain G75 became pleomorphic after culti-
vation in the stock culture collection. Pleomorphism is 
defined in mycology as a degenerative change in a fungus 
that converts the colony into one that is completely void of 
characteristic spores required for identification (Ajello) 
et al.) 1963). Pleomorphism is apparently irreversible. 
Strain G75 produced no spores~ only mycel ium. Strain 3330 
exhibited good growth on Sabouraudus with phosphate ion, 
many macroconidia and few microconidia were formed. This 
same strain on synthetic medium 1 showed less growth than 
on Sabouraudis, but the number of microconidia formed was 
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higher, Because of the greater amount of growth on 
Sabouraudis with phosphate~ this medium was selected to 
grow this strain of ~. capsulatume Strain 2645 of He 
capsulatum was chosen because it produced an abundance of 
both types of spores. Strain G17M was chosen to represent 
the species in the yeast phase because of previous character-
ization of the organism at the University of Utah o 
The intravenous route of challenge for infection of 
mice was chosen because of its superiority to other routes 
of infection for producing deaths in micee 
For our studies intracerebral injections have not been 
used because of the fol lowing problems: 1) a meningitis is 
produced which is rarely found in hosts naturally infected 
or in animals experimentally infected via other routes; 2) 
the volume of inoculum must necessarily be small; 3) the 
location of injections is not exact and deaths may be 
produced by focal brain lesions; 4) intracerebral injections 
are not made easily in most other species of laboratory 
animals e 
The intraperitoneal route of immunization was used. 
Previous workers (Hill and Marcus, 1959) had found the 
intraperitoneal route as effective as intramuscular, sub-
cutaneous or intravenous inoculations. The potency ratio 
for the comparison of normal groups to the other four groups 
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was found to be 2.4 with 95% confidence I imits of 1.25 to 45. 
In this thesis data were presented which permitted 
calculation of an estimate of the extent of resistance 
induced by immunization. This estimate is defined as the 
potency ratio, i.e., the ratio of the LD50 estimates for 
the control and to that of the immunized groups. The graphic 
method employed was modified by Litchfield and Wilcoxon 
(1949) from a method previously described (Miller and Tainter, 
1944) for estimating lethal dose 50 and standard deviation. 
The procedure involved fitting dose-response I ines by eye 
and calculation of LD50 and its error. By means of graphs 
and nomograms potency ratios and their errors were calculated. 
Challenge of the accuracy of the method by Finney (1952) 
was effectively answered by Litchfield and Wilcoxon (1953). 
Since the method of analysis was based on the assumption 
of a dose-response relationship, the adaptation to data 
presented here was val id only if there existed a direct 
relationship between challenge dose of organisms and mortal ity. 
Although the dose-response characteristic following organism 
challenge was clearly evident for normal mice, this parameter 
was less apparent for the immunized animals. The data have 
indicated that a challenge dose-mortal ity response relation-
ship did exist with immunized as well as normal mice: 
therefore the appl ication of the method of analysis was 
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justified. However, the shal low slopes of dose-response 
1 ines lead to a wide range in the confidence 1 imits. 
Intraperitoneal vaccination of the mice with cell free 
extract of strain GIO, a strain whose sporulation number 
indicated macroconidia production, and intravenous 
challenge (administered ten days postvaccination) gave the 
following potency ratios with the vaccination amounts in 
mil 1 i gram s 0 f dry wei g h t: 3 m g, 3 1; 1 m g, 24 ; o. 4 m g ~ 1 8 . 5 ; 
and O. 1 mg9 5.0. Analysis of the potency ratios for this 
strain depended on the finding that the LD50 values of the 
sal ine controls were 4.2 x 105 and 7.0 x 105. There was a 
definite dose-response relationship between the potency 
ratios. Careful observation of the mortal ity ratios com-
paring sal ine controls and various immunized groups yielded 
other dose-response relationships. Finally, analysis of 
results of culture of organs from survivors showed a dose-
response dependence. From this information one could deduce 
that as the dose of the vaccine is increased the mortal ity 
ratio~ per cent deaths, culture results decrease and the 
LD50 values increase, i.e., it required greater numbers of 
organisms as a challenge dose to achieve the same effect. 
For example at a challenge dose of 1 x 106 the per cent 
deaths in the sal ine control group was 38% and it was also 
38% for the group immunized with 0.1 mg dry weight cell 
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free extract. For the group immunized with 0.4 mg of the 
cell free extract, the deaths reached 11%. Looking at a 
challenge dose of 1 x 107 , the per cent deaths in the sal ine 
control group was 100%, 20% for 0.8 mg, 45% for 0.4 mg and 
60% for 0.1 mg. The per cent culture positive data yielded 
similar results as follows: 60% for 0.8 mg, 90% for 0.4 mg 
and 100% for 0.1 mg. 
In animals vaccinated with 7.3 x 104 whole macroconidia 
of strain GIO the potency ratio was 3.4. This ratio was 
sma1 ler than any of the values obtained with the cell free 
extract vaccine. The comparison can be made only with the 
understanding that the dry weight of the whole macroconidia 
was unknown. 
Similar dose-response relationships were observed in 
the vaccination with strain G75. The potency ratios that 
could be calculated were for 2 mg a value of 20; for 0.4 
mg, 4.7 and for 0.1 mg a value of 10. The dose-response 
relationship was unapparent in this case since the 0.1 mg 
ratio was higher than the 0.4 mg. 
Strain 3330 and strain 2645 of H. capsulatum yielded 
similar dose-response relationships with the potency ratios 
increasing as the dry weight of the vaccine increased. 
The cell free extract of yeast phase cells of strain 
G17M yielded potency ratios of 23 for 0.4 mg and 11.5 for 
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0 0 1 mgo Whole formal in-killed yeast cells used as a vaccine 
gave potency ratios of 7.2 for 106 cells and 11.4 for 
5 x 10 7 cells. Hi 11 and Marcus (1959) using a vaccine 
prepared from 4 x 107 cells prepared from strain G17M or 
6651, obtained a potency ratio of 5.3 (1.21-23) when the mice 
were challenged with G17M. These two results do not necessarily 
conf1 ict since the immunization procedures used differ and 
also the strain of H. capsu1atum used to challenge the 
immunized mice. Knight and Marcus (1958), in animals 
vaccinated with approximately 10 7 whole killed organisms, 
found a potency ratio of 7.6. The difference in the data 
reported in this thesis, between 1 x 106 cells and 5 x 107 
cells, i .e o approximately a 50 fold increase in the number 
of cells used to immunize, deserves further study. 
Two of the strains of ~o capsulatum studied, G10 and 
G17M, had similar potency ratios with regard to vaccine 
prepared from cell free extract. Strain G10 had a potency 
value of 18.5 (6-57) for 0.4 mg, whereas strain GJ7M had 
a potency ratio of 23 (7.8-69) for 004 mg. Values were 
similar for 0.1 mg dry weight of vaccine: strain G10, 5.0 
(1.6-15) and strain G17M, 11.5 (3.6-38). The vaccine 
prepared from strain G10 was from the mycel ial phase and 
according to the sporulation number this strain produced 
mainly macroconidia. The vaccine from strain G17M was 
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prepared from the yeast phase of the organism. Using the 
carbohydrate to protein ratio, strain GIO and strain G17M 
had similar chemical composition. Strain GIO had a ratio 
of 57 and strain G17M a ratio of 56~ There was a suggestion 
of a relationship between chemical composition and immunizing 
capacity. 
Knight, Hill and Marcus (1959) studied the immuno-
genicity of a vaccine prepared from a polysaccharide moiety 
of the yeast phase growth of H. capsulatum. The polysaccharide 
was capable of stimulating active resistance against intra-
~nously induced histoplasmosis in mice. Fol lowing intra-
peritoneal vaccination of mice with graded doses or a single 
dose, both of which totaled 1 mg of polysaccharide, the 
potency ratio for both groups was approximately 4.3. 
The remaining mycel ial phase vaccines prepared from 
strains G75, 2645, and 3330 had low carbohydrate to protein 
ratio, i.e., the percentage of protein found in these 
vaccines was higher. Strain G75 had both the highest 
carbohydrate and protein percentage. 
The relationship between dry weight, protein, and poly-
saccharide content of the mycel ial phase cell walls of 
H. capsulatum has been previously reported by McNall (1962). 
The protein content was 11.2% of the dry weight of isolated 
cell walls. The polysaccharide was reported as 30.0%. 
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Studies on six strains of yeast phase~. capsu1atum 
by Pine, Boone and McLaugh1 in (1966) showed protein content 
ranging from 7-38% and carbohydrate content ranging from 
7-31%. 
The values for cell free extracts of myce1 ial phase of 
the fungus reported in this thesis ranged from 33-47% 
carbohydrate for four strains. The protein content ranged 
from 0.6% to 7.1% based on dry weight of the mycel ial 
phase. The yeast phase cell free extract of G17M contained 
39% carbohydrate and 0.7% protein whereas the whole cells 




Twenty-three strains of H. capsulatum were characterized 
as to: 1) macroscopic appearance of the fungus on various 
media; 2) differential spore production on various media; 
3) intravenous LDSO of the yeast phase of certain strains 
of the organism; and 4) immunogenic capacity of vaccines 
prepared from various elements of the selected strains of 
the fungus. 
Results of experiments reflected apparent strain differ-
ences which exist among the species H. capsulatum. The 
first difference was morphological and might be related 
to the nitrogen source contained in the media. Sabouraud's 
medium with phosphate supported the best growth. The 
remaJnder of the media supported mycel ial growth in the 
following comparative order from good to scant: modified 
Sautonls, synthetic 2, synthetic 1, and synthetic 3. 
Synthetic 3 supported growth which was scant and del icate. 
Variations were also noted in the sporulation charac-
teristics of each strain grown on the various media. The 
measurements of spore sizes were consistant with values 
reported by other workers. Sabouraud's medium with phosphate 
produced larger macroconidia than the other media studied. 
Larger microconidia were produced on Sauton's medium than 
spores formed on the remaining media. The macroconidial 
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and microconidial spores ranged in size from 6.5 to 14.3 u 
and 2Q3 to 5.8 u respectively. The relative measurement 
of numbers of spores produced by each strain were based on 
a rank system. Strain G10 and 2870 produced a predominance 
of macroconidia as indicated by the sporulation number. Two 
of the 23 strains (G75 and 2586) produced only microconidia. 
Two strains, G17M and 2888, produced equal numbers of both 
spore types. The remaining strains yielded sporulation 
numbers that varied about those of the above described 
strains. The medium which produced the macroconidia best 
was Sabouraud's with phosphate. Synthetic 1 and 2, and 
modified Sauton's produced mainly microconidia. The remain-
ing medium, synthetic medium 3, produced sparse but equal 
numbers of both spore types. 
The intravenous L050 of selected yeast phase strains of 
H. capsulatum were studied. Significant differences in viru-
lence were noted. Strain 3154 had an L050 value of 3.0 x 105. 
At the other extreme, the L0 50 for strain 2813 was 3.0 x 10
8
, 
The values of the remaining strains fell between these two 
L050 values. The yeast phase of strain 3154 was used as the 
challenge organism in the immunization experiments. 
Vaccines prepared from G10, G17M, 2645, and 3330 were 
used to imunize mice. After challenge with the yeast phase 
of 3154, the potency ratios were determined. The vaccine 
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prepared from the mycel ial phase of GIG cell free extract 
and the cell free extract prepared from the yeast phase of 
G17M had similar potency ratios. These two vaccines, GIG 
and Gl7M had similar chemical composition also, with high 
carbohydrate and low protein content. The remaining vaccines, 
prepared either from cell free extracts or whole cells, 
yielded potency ratios that varied from 1.5 to 20.0, with 
no correlation between chemical composition and potency 
ratio. 
The 23 strains of H. capsulatum studied were isolated 
from human and animal sources, and from soils. The strains 
differed in mycel ial phase morphology, mouse virulence, and 
immunogenic capacity as determined by the results of these 
experiments. 
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RESEARCH PROPOSALS 
10 Investigation in depth should be undertaken of the 
chemical composition and morphologic and antigenic 
structure of the soluble, extracellular growth products~ 
cell walls, membrane and cytoplasmic fractions of 
Histoplasma capsulatum. 
2. The relationship of diagnostic and protective antigens 
with cell composition and structure of H. capsulatum 
remains unknown and requires studYa 
3. Further studies on the critical separation of the spores 
and mycel ium of H. capsulatum would yield specific 
information with regard to the chemical composition of 
these elements of H. capsulatum. 
4. The use of aerosol challenge, using purified spore and 
mycel ial elements, might yield more specific information 
concerning the mechanism of infection in experimental 
pulmonary histoplasmosis. 
5. Immunity studies util izing vaccines produced from various 
elements of He capsulatum and subsequent challenge of 
immunized animals with either purified viable microconidia 
or macroconidia would yield significant basic immuno-
mycologic information. 
2 
6. Epidemiological studies on a significant sample of Utah 
residents to determine the incidence of skin test 
sensitivity to~. capsulatum and Blastomyces dermatitidis 
should be accompl ished correlating skin test data with 
attempts to isolate these fungi. 
7. Relatively few pertinent data are available to indicate 
the potential cl inical usefulness of antifungal vaccination. 
Possibly such information could be obtained by immunity 
trials in a variety of hosts challenged under conditions 
that simulate or approximate natural exposure. 
8. The significance of delayed hypersensitivity in the 
chronic fungal diseases in unknown and merits further 
study. 
9. Studies must be pursued involving the relationship of the 
use of immunosuppressive drugs and opportunistic mycotic 
pathogens in patients that have received or are about to 
receive transplanted organs. 
10. Further studies are indicated of the relationship of the 
various strains of ~. capsulatum and the morphology, 
vl,ulence j and spore production of these strains. 
